Steven J. Frank, M.D.

Peer-Reviewed Articles

1. Hartsell WF, Simone CB, Godes D, Maggiore J, Mehta MP, Frank SJ, Metz JM, Choi JI. Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy. Int J Radiat Oncol Biol Phys 119(4):1069-1077, 2024. e-Pub 2023. PMID: 38163519.
2. Burus T, VanHelene AD, Rooney MK, Lang Kuhs KA, Christian WJ, McNair C, Mishra S, Paulino AC, Smith GL, Frank SJ, Warner JL. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment. JAMA Netw Open 7(5):e2410670, 2024. e-Pub 2024. PMID: 38758559.
3. Wang L, Ding Y, Bruno TL, Stafford RJ, Lin E, Bathala TK, Sanders JW, Ning MS, Ma J, Klopp AH, Venkatesan A, Wang J, Martirosyan KS, Frank SJ*. A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS). Cancers (Basel) 16(10), 2024. e-Pub 2024. PMID: 38792000.
4. Orlandi E, Fontana G, Licitra L, Tinelli C, Camarda AM, Grau C, Frank SJ*. Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysis. Radiother Oncol 193:110122, 2024. e-Pub 2024. PMID: 38309585.
5. Goldfarb J, Fan J, de Sousa LG, Akhave N, Myers J, Goepfert R, Manisundaram K, Zhao J, Frank SJ, Moreno A, Ferrarotto R, Esmaeli B. Neoadjuvant Chemotherapy Alone or Combined with EGFR-Directed Targeted Therapy or Anti-PD-1 Immunotherapy for Locally Advanced Lacrimal Sac and Nasolacrimal Duct Carcinomas. Semin Ophthalmol:1-7. e-Pub 2024. PMID: 38500295.
6. McCall NS, Frank SJ, Stokes WA. The Case for Allowing Proton Beam Therapy on Head and Neck Cooperative Group Studies. JAMA Oncol 10(3):289-290, 2024. PMID: 38206607.
7. Goldberg H, Jiang X, Fan J, Zhao J, Ning J, Williams M, Frank SJ, Moreno A, Gunn B, Ferrarotto R, Esmaeli B. Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmic Plast Reconstr Surg 40(4):419-425, 2024. e-Pub 2024. PMID: 38319188.
8. Sosa AJ, Thames HD, Sanders JW, Choi SL, Nguyen QN, Mok H, Ron Zhu X, Shah S, Mayo LL, Hoffman KE, Tang C, Lee AK, Pugh TJ, Kudchadker R, Frank SJ*. Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center. Radiother Oncol 188:109854, 2023. e-Pub 2023. PMID: 37597805.
9. Zhao Z, Frank SJ, Ning J, Zhao J, Jiang X, Wang XA, Schefler AC, Hanna E, Moreno A, Gunn B, Ferrarotto R, Esmaeli B. Visual outcome and ocular complications in patients with lacrimal gland carcinoma after eye-sparing surgery and adjuvant radiation therapy. Br J Ophthalmol 107(12):1914-1919, 2023. e-Pub 2023. PMID: 36229179.
10. Choi JI, Simone CB, Lozano A, Frank SJ*. Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy. Semin Radiat Oncol 33(4):407-415, 2023. PMID: 37684070.
11. Andring LM, Abu-Gheida I, Bathala T, Yoder AK, Manzar GS, Maldonado JA, Frank SJ, Choi S, Nguyen QN, Hoffman K, McGuire SE, Mok H, Aparicio A, Chapin BF, Tang C. Definitive local therapy for T4 prostate cancer associated with improved local control and survival. BJU Int 132(3):307-313, 2023. e-Pub 2023. PMID: 37057728.
12. Michalski JM, Winter KA, Prestidge BR, Sanda MG, Amin M, Bice WS, Gay HA, Ibbott GS, Crook JM, Catton CN, Raben A, Bosch W, Beyer DC, Frank SJ, Papagikos MA, Rosenthal SA, Barthold HJ, Roach M, Moughan J, Sandler HM. Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial. J Clin Oncol 41(24):JCO2201856, 2023. e-Pub 2023. PMID: 37315297.
13. Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, Garden AS, Gunn B, Lee A, Moreno AC, Morrison WH, Phan J, Rosenthal DI, Spiotto M, Frank SJ*. Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio. Cancers (Basel) 15(17), 2023. e-Pub 2023. PMID: 37686597.
14. Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study. Radiother Oncol 184:109672, 2023. e-Pub 2023. PMID: 37059334.
15. Cao W, Li Y, Zhang X, Poenisch F, Yepes P, Sahoo N, Grosshans D, McGovern S, Gunn GB, Frank SJ, Zhu XR. Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma. J Appl Clin Med Phys 24(7):e13954, 2023. e-Pub 2023. PMID: 36913484.
16. Tang C, Sanders J, Thames H, Swanson DM, Crook JM, Bruno T, Blanchard P, Ciezki J, Keyes M, Song D, Singh T, Merrick G, Stock R, Sullivan FJ, Mok H, Millar J, Frank SJ*. Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. Radiother Oncol 183:109599, 2023. e-Pub 2023. PMID: 36889593.
17. Lee NY, Harris J, Kim J, Garden A, Mechalakos J, Pfister DG, Chan ATC, Hu K, Colevas AD, Frank S, Shenouda G, Bar-Ad V, Waldron JN, Harari PM, Raben A, Torres-Saavedra P, Le QT. Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. JAMA Netw Open 6(6):e2316094, 2023. e-Pub 2023. PMID: 37266942.
18. Vazquez I, Gronberg MP, Zhang X, Court LE, Zhu XR, Frank SJ, Yang M. A deep learning-based approach for statistical robustness evaluation in proton therapy treatment planning: a feasibility study. Phys Med Biol 68(9), 2023. e-Pub 2023. PMID: 37040785.
19. Zhao J, Jiang X, Hanna E, Su SY, Moreno A, Gunn B, Frank SJ, Ferrarotto R, Ning J, Esmaeli B. Orbital and periocular complications in patients with sinonasal tumours with orbital invasion. Br J Ophthalmol. e-Pub 2023. PMID: 36707226.
20. Frank SJ. A CALL TO ARMS: The Case for MRI-Assisted Radiosurgery (MARS) vs. Stereotactic Body Radiation Therapy or Robotic-Assisted Radical Prostatectomy. Brachytherapy 22(1):12-14, 2023. PMID: 36725197.
21. Maroongroge S, De B, Woodhouse KD, Bassett RL, Lee P, Bloom ES, Smith GL, Frank SJ, Li J, Perkins G, Das P, Koong AC, Smith BD, Wang C. Physician Perspectives on Telemedicine in Radiation Oncology. Adv Radiat Oncol 8(2):101005, 2023. e-Pub 2022. PMID: 36311822.
22. Sanders JW, Tang C, Kudchadker RJ, Venkatesan AM, Mok H, Hanania AN, Thames HD, Bruno TL, Starks C, Santiago E, Cunningham M, Frank SJ*. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry. Brachytherapy 22(6):822-832, 2023. e-Pub 2023. PMID: 37716820.
23. Ng SP, Cardenas CE, Bahig H, Elgohari B, Wang J, Johnson JM, Moreno AC, Shah SJ, Garden AS, Phan J, Gunn GB, Frank SJ, Ding Y, Na L, Yuan Y, Urbauer D, Mohamed ASR, Rosenthal DI, Morrison WH, MacManus MP, Fuller CD. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study. Curr Oncol 29(9):6303-6313, 2022. e-Pub 2022. PMID: 36135064.
24. Yang M, Wang X, Guan F, Titt U, Iga K, Jiang D, Takaoka T, Tootake S, Katayose T, Umezawa M, Schüler E, Frank SJ, Lin SH, Sahoo N, Koong AC, Mohan R, Zhu XR. Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for FLASH experiments. Phys Med Biol 67(16), 2022. e-Pub 2022. PMID: 35853442.
25. Taku N, Chronowski G, Brandon Gunn G, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 113(5):1054-1062, 2022. e-Pub 2022. PMID: 35504500.
26. Chen M, Wang Z, Jiang S, Sun J, Wang L, Sahoo N, Brandon Gunn G, Frank SJ, Xu C, Chen J, Nguyen QN, Chang JY, Liao Z, Ronald Zhu X, Zhang X. Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy. Sci Rep 12(1):9178, 2022. e-Pub 2022. PMID: 35655073.
27. Sanders JW, Frank SJ*. Erratum to: Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS). Magn Reson Med. 2019;81:3888-3900. Magn Reson Med 87(6):3024, 2022. e-Pub 2022. PMID: 35122300.
28. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ*. Computer-aided segmentation on MRI for prostate radiotherapy, Part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability. Radiother Oncol 169:132-139, 2022. e-Pub 2021. PMID: 34979213.
29. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ*. Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry. Radiother Oncol 169:124-131, 2022. e-Pub 2021. PMID: 34921895.
30. Sanders JW, Kudchadker RJ, Tang C, Mok H, Venkatesan AM, Thames HD, Frank SJ*. Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy. Radiol Artif Intell 4(2):e210151, 2022. e-Pub 2022. PMID: 35391775.
31. Cardenas CE, Blinde SE, Mohamed ASR, Ng SP, Raaijmakers C, Philippens M, Kotte A, Al-Mamgani AA, Karam I, Thomson DJ, Robbins J, Newbold K, Fuller CD, Terhaard C, On Behalf Of The , Bahig H, Blanchard P, Dehnad H, Doornaert P, Elhalawani H, Frank SJ, Garden A, Gunn GB, Hamming-Vrieze O, Kamal M, Kasperts N, Lee LW, McDonald BA, McPartlin A, Meheissen MA, Morrison WH, Navran A, Nutting CM, Pameijer F, Phan J, Poon I, Rosenthal DI, Smid EJ, Sykes AJ. Comprehensive Quantitative Evaluation of Variability in MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study. Int J Radiat Oncol Biol Phys. e-Pub 2022. PMID: 35124134.
32. Stieb S, Engeseth GM, Mohamed ASR, He R, Perez-Martinez I, Rock S, Deshpande TS, Garden AS, Rosenthal DI, Frank SJ, Gunn GB, Fuller CD. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients. Acta Oncol 61(2):146-152, 2022. e-Pub 2022. PMID: 35060430.
33. Sousa LG, Wang K, Torman D, Binks BJ, Rubin ML, Andersen CR, Lewis WE, Rivera MJ, Kaya D, El-Naggar AK, Hanna EY, Esmaeli B, Frank SJ, Bell D, Glisson BS, Rodon J, Meric-Bernstam F, Lee JJ, Ferrarotto R. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Cancer 128(3):509-518, 2022. e-Pub 2021. PMID: 34661906.
34. Engeseth GM, Hysing LB, Yepes P, Pettersen HES, Mohan R, Fuller CD, Stokkevåg CH, Wu R, Zhang X, Frank SJ, Gunn GB. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. Acta Oncol 61(2):1-8, 2022. e-Pub 2021. PMID: 34534047.
35. Lin SH, Liao K, Lei X, Verma V, Shaaban S, Lee P, Chen AB, Koong AC, Hoftstetter WL, Frank SJ, Liao Z, Shih YT, Giordano SH, Smith GL. Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy. Int J Part Ther 9(1):18-27, 2022. e-Pub 2022. PMID: 35774487.
36. Kamrava M, Thaker N, Small W, Frank SJ*. Driving accountable care with brachytherapy. Brachytherapy 21(1):4-5, 2022. e-Pub 2021. PMID: 34930712.
37. Thaker NG, Kudchadker RJ, Incalcaterra JR, Bathala TK, Kaplan RS, Agarwal A, Kuban DA, Frank BD, Das P, Feeley TW, Frank SJ*. Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing. Brachytherapy 21(1):49-54, 2022. e-Pub 2021. PMID: 34389265.
38. van Dijk LV, Frank SJ, Yuan Y, Gunn B, Moreno AC, Mohamed ASR, Preston KE, Qing Y, Spiotto MT, Morrison WH, Lee A, Phan J, Garden AS, Rosenthal DI, Langendijk JA, Fuller CD. Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy. Clin Transl Radiat Oncol 32:35-40, 2022. e-Pub 2021. PMID: 34841093.
39. Shah C, Vicini F, Beriwal S, Thaker N, Frank SJ, Rossi P, Orio P, Chang AJ, Joshi N, Campbell SR, Naghavi A, Chao S, Kamrava M, Deufel CL, Mourtada F, Suh JH. American brachytherapy society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy. Brachytherapy 21(1):63-74, 2022. e-Pub 2021. PMID: 34732290.
40. Engeseth GM, He R, Mirkovic D, Yepes P, Mohamed ASR, Stieb S, Fuller CD, Wu R, Zhang X, Hysing LB, Pettersen HES, Stokkevåg CH, Mohan R, Frank SJ, Gunn GB. Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer. Int J Radiat Oncol Biol Phys 111(3):684-692, 2021. e-Pub 2021. PMID: 34153379.
41. King MT, Keyes M, Frank SJ, Crook JM, Butler WM, Rossi PJ, Cox BW, Showalter TN, Mourtada F, Potters L, Stock RG, Kollmeier MA, Zelefsky MJ, Davis BJ, Merrick GS, Orio PF. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement. Brachytherapy 20(6):1114-1129, 2021. e-Pub 2021. PMID: 34509378.
42. Lindemann A, Patel AA, Tang L, Tanaka N, Gleber-Netto FO, Bartels MD, Wang L, McGrail DJ, Lin SY, Frank SJ, Frederick MJ, Myers JN, Osman AA. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Mol Cancer Ther 20(7):1257-1269, 2021. e-Pub 2021. PMID: 33947685.
43. Cao J, Zhang X, Jiang B, Chen J, Wang X, Wang L, Sahoo N, Zhu XR, Ye R, Blanchard P, Garden AS, Fuller CD, Gunn GB, Frank SJ*. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol 160:32-39, 2021. e-Pub 2021. PMID: 33839202.
44. Elhalawani H, Cardenas CE, Volpe S, Barua S, Stieb S, Rock CB, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, Mohamed ASR, Court LE, Hutcheson KA, Brandon Gunn G, Rosenthal DI, Frank SJ, Garden AS, Rao A, Fuller CD. 18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer. Clin Transl Radiat Oncol 29:93-101, 2021. e-Pub 2021. PMID: 34195391.
45. Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Spiotto MT, Chronowski G, Shah SJ, Mayo LL, Gross ND, Ferrarotto R, Zhu XR, Zhang X, Frank SJ*. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy. Curr Treat Options Oncol 22(6):54, 2021. e-Pub 2021. PMID: 34086150.
46. Grossberg AJ, Rock CD, Edwards J, Mohamed ASR, Ruzensky D, Currie A, Rosemond P, Phan J, Gunn GB, Frank SJ, Morrison WH, Garden AS, Fuller CD, Rosenthal DI. Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy. Radiother Oncol 159:21-27, 2021. e-Pub 2021. PMID: 33736997.
47. Allen CJ, Eska JS, Thaker NG, Feeley TW, Kaplan RS, Huey RW, Tzeng CD, Lee JE, Frank SJ, Aloia TA, Gottumukkala V, Katz MHG. Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative. J Surg Res 262:115-120, 2021. e-Pub 2021. PMID: 33561722.
48. Hang Q, Zeng L, Wang L, Nie L, Yao F, Teng H, Deng Y, Yap S, Sun Y, Frank SJ, Chen J, Ma L. Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance. Nat Commun 12(1):4033, 2021. e-Pub 2021. PMID: 34188037.
49. Ford JR, Rubin ML, Frank SJ, Ning J, Debnam JM, Bell D, El-Naggar A, Ferrarotto R, Esmaeli B. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma. Br J Ophthalmol 105(6):768-774, 2021. e-Pub 2020. PMID: 32680839.
50. Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522. Oral Oncol 116:105241, 2021. e-Pub 2021. PMID: 33640577.
51. Guo TW, Saiyed F, Yao CMKL, Kiong KL, Martinez J, Sacks R, Lee JJ, Moreno AC, Frank SJ, Rosenthal DI, Glisson BS, Ferrarotto R, Mott FE, Johnson FM, Myers JN. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation. Cancer. e-Pub 2021. PMID: 33873251.
52. Tang C, Lei X, Smith GL, Pan HY, Hoffman KE, Kumar R, Chapin BF, Shih YT, Frank SJ, Smith BD. Influence of Geography on Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys 109(5):1286-1295, 2021. e-Pub 2020. PMID: 33316361.
53. Dahlstrom KR, Song J, Thall PF, Fuller CD, Hutcheson KA, Johnson FM, Gunn GB, Phan J, Frank SJ, Morrison WH, Ferrarotto R, Rosenthal DI, Sturgis EM, Garden AS. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer 127(8):1228-1237, 2021. e-Pub 2020. PMID: 33306202.
54. Stieb S, Mohamed ASR, He R, Zhu LL, McDonald BA, Wahid K, van Dijk LV, Ventura J, Ahmed S, McCoy L, Deshpande TS, Grant S, Reddy JP, Phan J, Garden AS, Rosenthal DI, Frank SJ, Gunn GB, Fuller CD. Development and Validation of a Contouring Guideline for the Taste Bud Bearing Tongue Mucosa. Radiother Oncol 157:63-69, 2021. e-Pub 2020. PMID: 33217499.
55. Hernandez M, Lee JJ, Yeap BY, Ye R, Foote RL, Busse P, Patel SH, Dagan R, Snider J, Mohammed N, Lin A, Blanchard P, Cantor SB, Teferra MY, Hutcheson K, Yepes P, Mohan R, Liao Z, DeLaney TF, Frank SJ*. The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial. Adv Radiat Oncol 6(2):100635, 2021. e-Pub 2020. PMID: 33732960.
56. Christopherson KM, Moreno AC, Elgohari B, Gross N, Ferrarotto R, Mohamed ASR, Brandon Gunn G, Goepfert RP, Mott FE, Shah SJ, David Fuller C, Reddy JP, Frank SJ, Morrison WH, Phan J, Rosenthal DI, Garden AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncol 113:105125, 2021. e-Pub 2020. PMID: 33360375.
57. Ferrarotto R, Mitani Y, McGrail DJ, Li K, Karpinets TV, Bell D, Frank SJ, Song X, Kupferman ME, Liu B, Lee JJ, Glisson BS, Zhang J, Aster JC, Lin SY, Futreal PA, Heymach JV, El-Naggar AK. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res 27(3):852-864, 2021. e-Pub 2020. PMID: 33172898.
58. Ng SP, Bahig H, Jethanandani A, Sturgis EM, Johnson FM, Elgohari B, Gunn GB, Ferrarotto R, Phan J, Rosenthal DI, Frank SJ, Fuller CD, Garden AS. Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy. Br J Cancer 124(3):628-633, 2021. e-Pub 2020. PMID: 33051590.
59. Sanders JW, Venkatesan AM, Levitt CA, Bathala T, Kudchadker RJ, Tang C, Bruno TL, Starks C, Santiago E, Wells M, Weaver CP, Ma J, Frank SJ*,. Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 109(2):614-625, 2021. e-Pub 2020. PMID: 32980498.
60. Bahig H, Fuller CD, Mitra A, Yoshida-Court K, Solley T, Ping Ng S, Abu-Gheida I, Elgohari B, Delgado A, Rosenthal DI, Garden AS, Frank SJ, Reddy JP, Colbert L, Klopp A. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer. Clin Transl Radiat Oncol 26:98-103, 2021. e-Pub 2020. PMID: 33367119.
61. Liu SM, Brooks ED, Rubin ML, MD Anderson Cancer Center Radiation Oncology Fellows Consortium, Grosshans DR, Frank SJ, McAleer MF, McGovern SL, Paulino AC, Woodhouse KD. Referral Patterns and Treatment Delays in Medulloblastoma: A Large Academic Proton Center Experience. Int J Part Ther 7(3):1-10, 2021. e-Pub 2020. PMID: 33604411.
62. Ebner DK, Frank SJ, Inaniwa T, Yamada S, Shirai T. The Emerging Potential of Multi-Ion Radiotherapy. Front Oncol 11:624786, 2021. e-Pub 2021. PMID: 33692957.
63. Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ*. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther 8(1):374-382, 2021. e-Pub 2021. PMID: 34285963.
64. Smith GL, Shih YT, Frank SJ*. Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy. Int J Part Ther 8(1):366-373, 2021. e-Pub 2021. PMID: 34285962.
65. Huang D, Frank SJ, Verma V, Thaker NG, Brooks ED, Palmer MB, Harrison RF, Deshmukh AA, Ning MS. Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date. Int J Part Ther 8(1):339-353, 2021. e-Pub 2021. PMID: 34285960.
66. Smith GL, Fu S, Ning MS, Nguyen DK, Busse PM, Foote RL, Garden AS, Gunn GB, Fuller CD, Morrison WH, Chronowski GM, Shah SJ, Mayo LL, Phan J, Reddy JP, Snider JW, Patel SH, Katz SR, Lin A, Mohammed N, Dagan R, Lee NY, Rosenthal DI, Frank SJ*. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer. Int J Part Ther 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
67. Ebner DK, Malouff TD, Frank SJ, Koto M. The Role of Particle Therapy in Adenoid Cystic Carcinoma and Mucosal Melanoma of the Head and Neck. Int J Part Ther 8(1):273-284, 2021. e-Pub 2021. PMID: 34285953.
68. Hanania AN, Zhang X, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Phan J, Reddy JP, Moreno A, Chronowski G, Shah S, Ausat N, Hanna E, Ferrarotto R, Frank SJ*. Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes. Int J Part Ther 8(1):261-272, 2021. e-Pub 2021. PMID: 34285952.
69. Sherry AD, Pasalic D, Gunn GB, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Sturgis EM, Gross ND, Gillison ML, Ferrarotto R, El-Naggar AK, Garden AS, Frank SJ*. Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life. Int J Part Ther 8(1):234-247, 2021. e-Pub 2021. PMID: 34285950.
70. Bahig H, Gunn BG, Garden AS, Ye R, Hutcheson K, Rosenthal DI, Phan J, Fuller CD, Morrison WH, Reddy JP, Ng SP, Gross ND, Sturgis EM, Ferrarotto R, Gillison M, Frank SJ*. Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer. Int J Part Ther 8(1):213-222, 2021. e-Pub 2021. PMID: 34285948.
71. Hug EB, Pelak M, Frank SJ, Fossati P. A Review of Particle Therapy for Skull Base Tumors: Modern Considerations and Future Directions. Int J Part Ther 8(1):168-178, 2021. e-Pub 2021. PMID: 34285944.
72. Spiotto MT, McGovern SL, Gunn GB, Grosshans D, McAleer MF, Frank SJ, Paulino AC. Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers. Int J Part Ther 8(1):155-167, 2021. e-Pub 2021. PMID: 34285943.
73. Gunn GB, Garden AS, Ye R, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ*. Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
74. Stieb S, Lee A, van Dijk LV, Frank S, Fuller CD, Blanchard P. NTCP Modeling of Late Effects for Head and Neck Cancer: A Systematic Review. Int J Part Ther 8(1):95-107, 2021. e-Pub 2021. PMID: 34285939.
75. Lin A, Chang JHC, Grover RS, Hoebers FJP, Parvathaneni U, Patel SH, Thariat J, Thomson DJ, Langendijk JA, Frank SJ*. PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors. Int J Part Ther 8(1):84-94, 2021. e-Pub 2021. PMID: 34285938.
76. Wang L, Fossati P, Paganetti H, Ma L, Gillison M, Myers JN, Hug E, Frank SJ*. The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma. Int J Part Ther 8(1):3-13, 2021. e-Pub 2021. PMID: 34285931.
77. Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank SJ, Followill D. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys 48(1):445-455, 2021. e-Pub 2020. PMID: 33176003.
78. Allen CJ, Thaker NG, Prakash L, Kruse BC, Feeley TW, Kaplan RS, Huey R, Frank SJ, Aloia TA, Gottumukkala V, Katz MHG. Communicating Value: Use of a Novel Framework in the Assessment of an Enhanced Recovery Initiative. Ann Surg 273(1):e7-e9, 2021. e-Pub 2020. PMID: 32568750.
79. Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton J, Sikora AG, Myers JN, Pickering CR. Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis. JCI Insight 5(23), 2020. e-Pub 2020. PMID: 33108350.
80. Chi WJ, Myers JN, Frank SJ, Aponte-Wesson RA, Otun AO, Nogueras-González GM, Li Y, Geng Y, Chambers MS. The effects of zinc on radiation-induced dysgeusia: a systematic review and meta-analysis. Support Care Cancer 28(12):1-12, 2020. e-Pub 2020. PMID: 32642950.
81. Sanders JW, Lewis GD, Thames HD, Kudchadker RJ, Venkatesan AM, Bruno TL, Ma J, Pagel MD, Frank SJ*. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 108(5):1292-1303, 2020. e-Pub 2020. PMID: 32634543.
82. Grant SR, Williamson TD, Stieb S, Shah SJ, David Fuller C, Rosenthal DI, Frank SJ, Garden AS, Morrison WH, Phan J, Moreno AC, Reddy JP, Cardoso RC, Liu AY, Wu RY, Gunn GB. A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer: IMRT, IMPT, and Tongue-Deviating Oral Stents. Adv Radiat Oncol 5(6):1359-1363, 2020. e-Pub 2020. PMID: 33305099.
83. Frank SJ, Mourtada F, Crook J, Orio PF, Stock RG, Petereit DG, Rossi PJ, Cox BW, Tang C, Kudchadker RJ, Bruno T, Ma J, Sanders J, Keyes M. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance. Brachytherapy 19(6):787-793, 2020. e-Pub 2020. PMID: 33132070.
84. Mesko S, Chapman BV, Tang C, Kudchadker RJ, Bruno TL, Sanders J, Das P, Pinnix CC, Thaker NG, Frank SJ*. Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents. Brachytherapy. e-Pub 2020. PMID: 32952054.
85. Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Phan J, Cardenas C, Ferrarotto R, Frank SJ, Rosenthal DI, Garden AS. Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Adv Radiat Oncol 5(5):929-935, 2020. e-Pub 2020. PMID: 33083655.
86. Stieb S, Perez-Martinez I, Mohamed ASR, Rock S, Bajaj N, Deshpande TS, Zaid M, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Reddy JP, Phan J, Morrison WH, Rosenthal DI, Koay EJ, Frank SJ, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors. Clin Transl Radiat Oncol 24:71-78, 2020. e-Pub 2020. PMID: 32642562.
87. Crook JM, Tang C, Thames H, Blanchard P, Sanders J, Ciezki J, Keyes M, Morris WJ, Merrick G, Catton C, Raziee H, Stock R, Sullivan F, Anscher M, Millar J, Frank SJ*. A biochemical definition of cure after brachytherapy for prostate cancer. Radiother Oncol 149:64-69, 2020. e-Pub 2020. PMID: 32442822.
88. Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C. Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. Int J Radiat Oncol Biol Phys 107(5):982-985, 2020. e-Pub 2020. PMID: 32353391.
89. Garden AS, Kamal M, Mohamed ASR, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Ferrarotto R, Rosenthal DI, Hutcheson KA, Fuller CD, Gunn GB. Neurologic sequelae following radiation with and without chemotherapy for oropharyngeal cancer: Patient reported outcomes study. Head Neck 42(8):2137-2144, 2020. e-Pub 2020. PMID: 32212359.
90. Boyce-Fappiano D, Bathala TK, Ye R, Pasalic D, Gjyshi O, Pezzi TA, Noticewala SS, McGinnis GJ, Maroongroge S, Kuban DA, Nguyen QN, McGuire SE, Hoffman KE, Choi S, Tang C, Kudchadker RJ, Frank SJ*. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy. e-Pub 2020. PMID: 32682778.
91. Brooks ED, Ning MS, Palmer MB, Gunn GB, Frank SJ, Shah AK. Strategic Operational Redesign for Successfully Navigating Prior Authorization Barriers at a Large-Volume Proton Therapy Center. JCO Oncol Pract 16(10):JOP1900533. e-Pub 2020. PMID: 32639929.
92. Pezzi TA, Ning MS, Thaker NG, Boyce-Fappiano D, Gjyshi O, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko S, Gandhi S, Chun S, Tang C, Frank SJ, Gomez DR. Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing. Clin Transl Radiat Oncol 23:80-84, 2020. e-Pub 2020. PMID: 32529054.
93. Simone CB, Plastaras JP, Jabbour SK, Lee A, Lee NY, Choi JI, Frank SJ, Chang JY, Bradley J. Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies. Semin Radiat Oncol 30(3):253-261, 2020. PMID: 32503791.
94. Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ*. Patient-Reported Outcomes, Physician-Reported Toxicities, and Treatment Outcomes in a Modern Cohort of Patients with Sinonasal Cancer Treated Using Proton Beam Therapy. Radiother Oncol 148:258-266, 2020. e-Pub 2020. PMID: 32417351.
95. Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy 19(4):484-490, 2020. e-Pub 2020. PMID: 32402544.
96. Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Brandon Gunn G, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ*. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol 148:133-139, 2020. e-Pub 2020. PMID: 32361662.
97. Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol 106:104665, 2020. e-Pub 2020. PMID: 32298994.
98. Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson C, Frank S, Followill D. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys. e-Pub 2020. PMID: 32506820.
99. Manzar GS, Lester SC, Routman DM, Harmsen WS, Petersen MM, Sloan JA, Mundy DW, Hunzeker AE, Amundson AC, Anderson JL, Patel SH, Garces YI, Halyard MY, McGee LA, Neben-Wittich MA, Ma DJ, Frank SJ, Whitaker TJ, Foote RL. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol 147:64-74, 2020. e-Pub 2020. PMID: 32234612.
100. Grant SR, Lei X, Hess KR, Smith GL, Matin SF, Wood CG, Nguyen Q, Frank SJ, Anscher MS, Smith BD, Karam JA, Tang C. Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation. Adv Radiat Oncol 5(3):495-502, 2020. e-Pub 2020. PMID: 32529146.
101. Stieb S, Mohamed ASR, Deshpande TS, Harp J, Greiner B, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Phan J, Reddy JP, Morrison WH, Rosenthal DI, Frank SJ, Fuller CD, Brandon Gunn G, MD Anderson Head and Neck Cancer Symptom Working Group. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?. Clin Transl Radiat Oncol 22:98-105, 2020. e-Pub 2020. PMID: 32373720.
102. Wang Z, Chen M, Sun J, Jiang S, Wang L, Wang X, Sahoo N, Gunn GB, Frank SJ, Nguyen QN, Liao Z, Chang JY, Zhu XR, Zhang X. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy. Radiother Oncol 146:200-204, 2020. e-Pub 2020. PMID: 32220701.
103. Ng SP, Bahig H, Jethanandani A, Pollard C, Berends J, Sturgis EM, Johnson FM, Elgohari B, Elhalawani H, Rosenthal DI, Skinner HD, Gunn GB, Phan J, Frank SJ, Mohamed ASR, Fuller CD, Garden AS. Lymphopenia during radiotherapy in patients with oropharyngeal cancer. Radiother Oncol 145:95-100, 2020. e-Pub 2020. PMID: 31931292.
104. Wang L, Cao J, Wang X, Lin E, Wang Z, Li Y, Li Y, Chen M, Wang X, Jiang B, Zhang R, Sahoo N, Zhang X, Zhu XR, Myers JN, Frank SJ*. Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells. Head Neck. e-Pub 2020. PMID: 32323895.
105. Ning MS, Palmer MB, Shah AK, Chambers LC, Garlock LB, Melson BB, Frank SJ*. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncol Pract:JOP1900437. e-Pub 2020. PMID: 32302271.
106. Tang C, Lei X, Smith GL, Pan HY, Hess K, Chen A, Hoffman KE, Chapin BF, Kuban DA, Anscher M, Tina Shih YC, Frank SJ, Smith BD. Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data. Pract Radiat Oncol. e-Pub 2020. PMID: 32298794.
107. Tom A, Bell D, Ford JR, Debnam JM, Guo Y, Frank SJ, Esmaeli B. Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) of the Lacrimal Gland. Ophthalmic Plast Reconstr Surg 36(5). e-Pub 2020. PMID: 32282452.
108. Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. Stereotactic Ablative Radiotherapy (SABR) for skull base malignancies: a systematic analysis of set-up and positioning accuracy. Pract Radiat Oncol. e-Pub 2020. PMID: 32240823.
109. Bahig H, Ng SP, Pollard C, Nguyen TP, Gunn GB, Rosenthal DI, Fuller CD, Frank SJ, Garden AS, Reddy JP, Morrison WH, Ferrarotto R, Hanna EY, DeMonte F, Su SY, Phan J. A prospective evaluation of health-related quality of life after skull base re-irradiation. Head Neck 42(3):485-497, 2020. e-Pub 2019. PMID: 31868271.
110. Chen M, Yepes P, Hojo Y, Poenisch F, Li Y, Chen J, Xu C, He X, Gunn GB, Frank SJ, Sahoo N, Li H, Zhu XR, Zhang X. Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy. Br J Radiol 93(1107):20190669, 2020. e-Pub 2019. PMID: 31799859.
111. Elhalawani H, Awan MJ, Ding Y, Mohamed ASR, Elsayes AK, Abu-Gheida I, Wang J, Hazle J, Gunn GB, Lai SY, Frank SJ, Ginsberg LE, Rosenthal DI, Fuller CD. Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. Sci Data 7(1):63, 2020. e-Pub 2020. PMID: 32081849.
112. Ng SP, Ajayi T, Schaefer AJ, Pollard C, Bahig H, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Phan J, Morrison WH, Johnson JM, Mohamed ASR, Sturgis EM, Fuller CD. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Cancer 126(4):749-756, 2020. e-Pub 2019. PMID: 31725906.
113. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer 126(3):506-514, 2020. e-Pub 2019. PMID: 31742674.
114. Wang L, Yang L, Han S, Zhu J, Li Y, Wang Z, Fan YH, Lin E, Zhang R, Sahoo N, Li Y, Zhang X, Wang X, Li T, Zhu XR, Zhu H, Heymach JV, Myers JN, Frank SJ*. Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy. Head Neck 42(2):289-301, 2020. e-Pub 2019. PMID: 31710172.
115. Wu RY, Liu AY, Yang J, Williamson TD, Wisdom PG, Bronk L, Gao S, Grosshan DR, Fuller DC, Gunn GB, Ronald Zhu X, Frank SJ*. Evaluation of the accuracy of deformable image registration on MRI with a physical phantom. J Appl Clin Med Phys 21(1):166-173, 2020. e-Pub 2019. PMID: 31808307.
116. Mesko S, Wang H, Tung S, Wang C, Pasalic D, Chapman BV, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Phan J. Estimating PTV margins in head and neck stereotactic ablative radiation therapy (SABR) through target site analysis of positioning and intrafractional accuracy. Int J Radiat Oncol Biol Phys 106(1):185-193, 2020. e-Pub 2019. PMID: 31580928.
117. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer 28(1):261-269, 2020. e-Pub 2019. PMID: 31037378.
118. Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope 130(1):146-153, 2020. e-Pub 2019. PMID: 30756394.
119. Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope 130(1):86-93, 2020. e-Pub 2019. PMID: 30706478.
120. Hanania AN, Kudchadker RJ, Bruno TL, Tang C, Anscher MS, Frank SJ*. MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy. Brachytherapy. e-Pub 2019. PMID: 31812590.
121. Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clin Cancer Res 25(23):7078-7088, 2019. e-Pub 2019. PMID: 31420360.
122. Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy. e-Pub 2019. PMID: 31786169.
123. Joint Head and Neck MRI-Radiotherapy Development Cooperative, Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD. Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients. Clin Transl Radiat Oncol 18:120-127, 2019. e-Pub 2019. PMID: 31341987.
124. Wu RY, Liu AY, Williamson TD, Yang J, Wisdom PG, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Gao S. Quantifying the accuracy of deformable image registration for cone-beam computed tomography with a physical phantom. J Appl Clin Med Phys. e-Pub 2019. PMID: 31541526.
125. Yang Z, Zhang X, Wang X, Zhu XR, Gunn B, Frank SJ, Chang Y, Li Q, Yang K, Wu G, Liao L, Li Y, Chen M, Li H. Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers. Radiother Oncol. e-Pub 2019. PMID: 31564553.
126. Lindemann A, Patel AA, Silver NL, Tang L, Liu Z, Wang L, Tanaka N, Rao X, Takahashi H, Maduka NK, Zhao M, Chen TC, Liu W, Gao M, Wang J, Frank SJ, Hittelman WN, Mills GB, Myers JN, Osman AA. COTI-2, a novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. Clin Cancer Res 25(18):5650-5662, 2019. e-Pub 2019. PMID: 31308060.
127. Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE, Nguyen QN, McGuire SE, Pollack A, Anscher MS. Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 104(4):790-797, 2019. e-Pub 2019. PMID: 30836166.
128. Ning MS, Gomez DR, Shah AK, Kim CR, Palmer MB, Thaker NG, Grosshans DR, Liao Z, Chapman BV, Brooks ED, Tang C, Rosenthal DI, Garden AS, Frank SJ, Gunn GB. The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care. Int J Radiat Oncol Biol Phys 104(4):724-733, 2019. e-Pub 2018. PMID: 30557675.
129. Ng SP, Pollard C, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer 125(11):1823-1829, 2019. e-Pub 2019. PMID: 30748005.
130. Sanders JW, Frank SJ, Kudchadker RJ, Bruno TL, Ma J. Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS). Magn Reson Med 81(6):3888-3900, 2019. e-Pub 2019. PMID: 30737827.
131. Lin TA, Garden AS, Elhalawani H, Elgohari B, Jethanandani A, Ng SP, Mohamed AS, Frank SJ, Glisson BS, Debnam JM, Sturgis EM, Phan J, Reddy JP, Fuller CD, Morrison WH, Skinner HD, Rosenthal DI, Gunn GB. Radiographic retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Cancer 125(9):1536-1546, 2019. e-Pub 2019. PMID: 30620385.
132. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy. e-Pub 2019. PMID: 30992185.
133. Ng SP, Pollard C, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol 3:22, 2019. e-Pub 2019. PMID: 31583278.
134. Yepes P, Adair A, Frank SJ, Grosshans DR, Liao Z, Liu A, Mirkovic D, Poenisch F, Titt U, Wang Q, Mohan R. Fixed- versus Variable-RBE Computations for Intensity Modulated Proton Therapy. Adv Radiat Oncol 4(1):156-167, 2019. e-Pub 2018. PMID: 30706024.
135. Moreno AC, Frank SJ, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Williamson TD, Holliday EB, Phan J, Blanchard P. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. Oral Oncol 88:66-74, 2019. e-Pub 2018. PMID: 30616799.
136. Wu RY, Liu AY, Wisdom P, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Palmer MB, Wages CA, Gillin MT, Yang J. Characterization of a new physical phantom for testing rigid and deformable image registration. J Appl Clin Med Phys 20(1):145-153, 2019. e-Pub 2018. PMID: 30580471.
137. Wang L, Han S, Zhu J, Wang X, Li Y, Wang Z, Lin E, Wang X, Molkentine DP, Blanchard P, Yang Y, Zhang R, Sahoo N, Gillin M, Zhu XR, Zhang X, Myers JN, Frank SJ*. Proton versus photon radiation-induced cell death in head and neck cancer cells. Head Neck 41(1):46-55, 2019. e-Pub 2018. PMID: 30561022.
138. Maenhout M, Peters M, Moerland MA, Meijer RP, van den Bosch MAAJ, Frank SJ, Nguyen PL, van Vulpen M, van der Voort van Zyp JRN. MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life. Radiother Oncol 129(3):554-560, 2018. e-Pub 2018. PMID: 30131183.
139. Woo KI, Sagiv O, Han J, Frank SJ, Kim YD, Esmaeli B. Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients. Ophthalmic Plast Reconstr Surg 34(6):570-574, 2018. e-Pub 2018. PMID: 29634603.
140. Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5(1):1, 2018. e-Pub 2018. PMID: 30482902.
141. Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. e-Pub 2018. PMID: 30447126.
142. Deshpande TS, Blanchard P, Wang L, Foote RL, Zhang X, Frank SJ*. Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review. Curr Treat Options Oncol 19(12):72, 2018. e-Pub 2018. PMID: 30411162.
143. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol 13:19-23, 2018. e-Pub 2018. PMID: 30386824.
144. Ng SP, Johnson JM, Gunn GB, Rosenthal DI, Skinner HD, Phan J, Frank SJ, Morrison W, Sturgis EM, Mott FE, Williams MD, Fuller CD, Garden AS. Significance of Negative Post-Treatment 18-FDG PET/CT Imaging in Patients with p16/HPV-positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 102(4):1029-1035, 2018. e-Pub 2018. PMID: 29960060.
145. Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):JCO2018779868, 2018. e-Pub 2018. PMID: 30106637.
146. Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer 18(1):903, 2018. e-Pub 2018. PMID: 30231854.
147. Grossberg AJ, Mohamed ASR, El Halawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173, 2018. e-Pub 2018. PMID: 30179230.
148. Sanders JW, Song H, Frank SJ, Bathala T, Venkatesan AM, Anscher M, Tang C, Bruno TL, Wei W, Ma J. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy. Brachytherapy. e-Pub 2018. PMID: 29880449.
149. Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8, 2018. e-Pub 2018. PMID: 29598944.
150. Yan Y, Yang J, Beddar S, Ibbott G, Wen Z, Court LE, Hwang KP, Kadbi M, Krishnan S, Fuller CD, Frank SJ, Yang J, Balter P, Kudchadker RJ, Wang J. A methodology to investigate the impact of image distortions on the radiation dose when using magnetic resonance images for planning. Phys Med Biol 63(8):085005, 2018. e-Pub 2018. PMID: 29528037.
151. Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg:1-10. e-Pub 2018. PMID: 29701557.
152. Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol 28(2):108-113, 2018. PMID: 29735186.
153. Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Ferrarotto R, Frank SJ, Skinner HD, Rosenthal DI, Garden AS. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Cancer 124(7):1415-1427, 2018. e-Pub 2018. PMID: 29338089.
154. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int 121(4):540-548, 2018. e-Pub 2017. PMID: 28941030.
155. Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YT, Smith BD. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol 36(18):JCO2017755371. e-Pub 2018. PMID: 29561693.
156. Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ*. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy 17(2):265-276, 2018. e-Pub 2017. PMID: 29269207.
157. Martin GV, Kudchadker RJ, Bruno TL, Frank SJ, Wang J. Comparison of prostate distortion by inflatable and rigid endorectal MRI coils in permanent prostate brachytherapy imaging. Brachytherapy 17(2):298-305, 2018. e-Pub 2017. PMID: 29169971.
158. Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, van der Heide UA, Frank SJ, Nill S, Oelfke U, van Herk M, Li XA, Mittauer K, Ritter M, Choudhury A, Tree AC. Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?. Int J Radiat Oncol Biol Phys 100(2):361-373, 2018. e-Pub 2017. PMID: 29353654.
159. Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2017. PMID: 29229325.
160. MD Anderson Head and Neck Cancer Symptom Working Group, Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol 126(1):75-80, 2018. e-Pub 2017. PMID: 29229507.
161. Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ*. Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol 28(1):53-63, 2018. PMID: 29173756.
162. Wang X, Li Y, Zhang X, Li H, Miyazaki K, Fujimoto R, Akiyama H, Gillin MT, Poenisch F, Sahoo N, Grosshans D, Gunn B, Frank SJ, Wang P, Lang J, Hou Q, Zhu XR. Synchrotron-Based Pencil Beam Scanning Nozzle with an Integrated Mini-Ridge Filter: A Dosimetric Study to Optimize Treatment Delivery. Cancers (Basel) 9(12):170, 2017. e-Pub 2017. PMID: 29236051.
163. Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128(6). e-Pub 2017. PMID: 29226334.
164. Maenhout M, Peters M, Van Vulpen M, Moerland MA, Meijer RP, Van Den Bosch MAAJ, Nguyen PL, Frank SJ, Van Der Voort Van Zyp JRN. Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer. Technol Cancer Res Treat 16(6):1194-1201, 2017. e-Pub 2017. PMID: 29333958.
165. MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. Radiat Oncol 12(1):186, 2017. e-Pub 2017. PMID: 29169353.
166. Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
167. Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. PMID: 28741749.
168. Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
169. MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
170. Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS. Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Oral Oncol 72:90-97, 2017. e-Pub 2017. PMID: 28797467.
171. Mohamed ASR, Wong AJ, Fuller CD, Kamal M, Gunn GB, Phan J, Morrison WH, Beadle BM, Skinner H, Lai SY, Quinlan-Davidson SR, Belal AM, El-Gowily AG, Frank SJ, Rosenthal DI, Garden AS. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Radiat Oncol 12(1):129, 2017. e-Pub 2017. PMID: 28806994.
172. Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck 39(8):1671-1679, 2017. e-Pub 2017. PMID: 28561956.
173. Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. PMID: 28464542.
174. Voong KR, Lal LS, Kuban DA, Pugh TJ, Swint JM, Godby J, Choi S, Lee AK, Schlembach PJ, Frank SJ, McGuire SE, Hoffman KE. Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial. Adv Radiat Oncol 2(3):249-258, 2017. e-Pub 2017. PMID: 29114589.
175. Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Blanchard P, Frank SJ*. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers. Brachytherapy 16(4):761-769, 2017. e-Pub 2017. PMID: 28501429.
176. Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer. Brachytherapy 16(4):790-796, 2017. e-Pub 2017. PMID: 28442277.
177. Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Frank SJ*. Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging. Brachytherapy 16(4):728-733, 2017. e-Pub 2017. PMID: 28284511.
178. Cardenas CE, Mohamed ASR, Tao R, Wong AJR, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys 98(3):532-540, 2017. e-Pub 2016. PMID: 28258898.
179. Frank SJ, Mourtada F, Crook J, Menard C. Use of magnetic resonance imaging in low-dose-rate and high-dose-rate prostate brachytherapy from diagnosis to treatment assessment: Defining the knowledge gaps, tehnical challenges, and barriers to implementation. Brachytherapy 16(4):672-678, 2017.
180. Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ*. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol 123(3):401-405, 2017. e-Pub 2017. PMID: 28549794.
181. Phan J, Frank SJ*. In Reply to Yamazaki, et al. Int J Radiat Oncol Biol Phys 97(4):868-869, 2017. PMID: 28244425.
182. Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ*. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol 7:201, 2017. e-Pub 2017. PMID: 28929085.
183. Blanchard P, Ménard C, Frank SJ*. Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow. Brachytherapy. e-Pub 2017. PMID: 28153700.
184. Keyes M, Merrick G, Frank SJ, Grimm P, Zelefsky MJ. American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review. Brachytherapy. e-Pub 2017. PMID: 28110898.
185. Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ*. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy. e-Pub 2017. PMID: 28063817.
186. Moghanaki D, Turkbey B, Vapiwala N, Ehdaie B, Frank SJ, McLaughlin PW, Harisinghani M. Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning. Semin Radiat Oncol 27(1):21-33, 2017. e-Pub 2016. PMID: 27986208.
187. Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Head Neck. e-Pub 2016. PMID: 28006086.
188. Wang L, Wang X, Li Y, Han S, Zhu J, Wang X, Molkentine DP, Blanchard P, Yang Y, Zhang R, Sahoo N, Gillin M, Zhu XR, Zhang X, Myers JN, Frank SJ*. Human papillomavirus status and the relative biological effectiveness of proton radiotherapy in head and neck cancer cells. Head Neck. e-Pub 2016. PMID: 28039958.
189. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
190. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer 122(21):3411-3412, 2016. e-Pub 2016. PMID: 27420634.
191. Blanchard P, Volk RJ, Ringash J, Peterson SK, Hutcheson KA, Frank SJ*. Assessing head and neck cancer patient preferences and expectations: A systematic review. Oral Oncol 62:44-53, 2016. e-Pub 2016. PMID: 27865371.
192. Wang L, Hoogcarspel SJ, Wen Z, Van Vulpen M, Molkentine DP, Kok J, Lin SH, Broekhuizen R, Ang KK, Bovenschen N, Raaymakers BW, Frank SJ*. Biological responses of human solid tumor cells to X-ray irradiation within a 1.5-Tesla magnetic field generated by a magnetic resonance imaging-linear accelerator. Bioelectromagnetics 37(7):471-80, 2016. e-Pub 2016. PMID: 27434783.
193. Thaker NG, Ali TN, Porter ME, Feeley TW, Kaplan RS, Frank SJ*. Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer. J Oncol Pract 12(9):813-20, 2016. e-Pub 2016. PMID: 27577622.
194. Blanchard P, Wong AJ, Gunn GB, Garden AS, Mohamed AS, Rosenthal DI, Crutison J, Wu R, Zhang X, Zhu XR, Mohan R, Amin MV, Fuller CD, Frank SJ*. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. Radiother Oncol. e-Pub 2016. PMID: 27641784.
195. Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-reported Urinary, Bowel and Sexual Function After Hypofractionated Intensity-Modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. Am J Clin Oncol 41(6). e-Pub 2016. PMID: 27635624.
196. Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ*. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 96(1):30-41, 2016. e-Pub 2016. PMID: 27325480.
197. Esmaeli B, Yin VT, Hanna EY, Kies MS, William WN, Bell D, Frank SJ*. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck 38(8):1258-62, 2016. e-Pub 2016. PMID: 27027275.
198. Pugh TJ, MD1; Choi S, MD2; Nogueras-Gonzalaez GM, MPH3; Nguyen QN, Mahmood U, Frank SJ, Mathai B, Zhu XR, Sahoo N, Gillin M, Kuban D, Hoffman K, McGuire S, Lee A. Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trail. International Journal of Particle Therapy 3(1):27-36, 2016.
199. McKeever MR, Sio TT, Gunn GB, Holliday EB, Blanchard P, Kies MS, Weber RS, Frank SJ*. Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. Chin Clin Oncol 5(4):54, 2016. e-Pub 2016. PMID: 27506808.
200. Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-Escalated Radiation in Men With Intermediate-Risk Prostate Cancer. Am J Clin Oncol 39(4):368-73, 2016. e-Pub 2014. PMID: 24732810.
201. Sio T, Lin H, Shi Q, Gunn GB, Cleeland C, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ*. Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Radiotherapy (IMRT) for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. International Journal of Radiation Oncology, 2016.
202. Wang J, Weygand J, Hwang KP, Mohamed AS, Ding Y, Fuller CD, Lai SY, Frank SJ, Zhou J. Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck Cancer. Sci Rep 6:30618, 2016. e-Pub 2016. PMID: 27461165.
203. Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ*. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. PMID: 27342249.
204. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 118(1):68-76, 2016. e-Pub 2015. PMID: 26059275.
205. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, 2016. e-Pub 2015. PMID: 26979544.
206. Sio TT, Lin HK, Shi Q, Gunn GB, Cleeland CS, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ*. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys 95(4):1107-14, 2016. e-Pub 2016. PMID: 27354125.
207. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 95(4):1117-31, 2016. e-Pub 2016. PMID: 27354127.
208. Lim TY, Kudchadker RJ, Wang J, Stafford RJ, MacLellan C, Rao A, Ibbott GS, Frank SJ*. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate post-implant assessment. Med Phys 43(7):4312, 2016. PMID: 27370146.
209. Suzuki K, Palmer MB, Sahoo N, Zhang X, Poenisch F, Mackin DS, Liu AY, Wu R, Zhu XR, Frank SJ, Gillin MT, Lee AK. Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapy. Med Phys 43(15-1178):3975, 2016. PMID: 27370116.
210. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Radiation Therapy (with or without neck surgery) for Phenotypic HPV-associated Oropharyngeal Cancer. Cancer 122(11):1702-7, 2016. e-Pub 2016. PMID: 27019396.
211. Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ*. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: Initial patient experience. J Contemp Brachytherapy 8(3):235-42, 2016. e-Pub 2016. PMID: 27504133.
212. Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank SJ, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma. JAMA Oncol 2(6):782-9, 2016. e-Pub 2016. PMID: 26891703.
213. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ*. A Multidisciplinary Orbit-Sparing Treatment Approach that Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys 95(1):344-52, 2016. e-Pub 2015. PMID: 26454680.
214. Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ*. Defining the Value Framework for Prostate Brachytherapy using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing. Brachytherapy 15(3):274-82, 2016. e-Pub 2016. PMID: 26916105.
215. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed ASR, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ*. Clinical outcomes and patterns of disease recurrence following intensity modulated proton therapy for oropharyngeal squamous carcinoma: Results from a single institution prospective study. International Journal of Radiation Oncology Biology Physics, 2016. PMID: 27084653.
216. Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Head Neck 38 Suppl 1:E452-8, 2016. e-Pub 2015. PMID: 25645649.
217. Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck 38 Suppl 1:E580-7, 2016. e-Pub 2015. PMID: 25782700.
218. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ*. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of nine cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 2016. e-Pub 2015. PMID: 26561041.
219. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 2016. e-Pub 2015. PMID: 25994561.
220. Lewis GD, Holliday EB, Kocak-Uzel E, Hernandez M, Garden AS, Rosenthal DI, Frank SJ*. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck 38 Suppl 1:E1886-95, 2016. e-Pub 2015. PMID: 26705956.
221. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck 38 Suppl 1:E1459-66, 2016. e-Pub 2015. PMID: 26560893.
222. Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck 38 Suppl 1:E2091-9, 2016. e-Pub 2016. PMID: 26920665.
223. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck 38 Suppl 1:E1554-61, 2016. e-Pub 2015. PMID: 26595157.
224. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-Based Peer-Review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract 12(4):e476-86, 2016. e-Pub 2016. PMID: 26931402.
225. Holliday E, Bhattasali O, Kies MS, Hanna E, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Phan J, Zhu R, Zhang X, Frank SJ*. Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma. International Journal of Particle Therapy, 2016.
226. Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, Kuban D, Frank SJ, Lee AK, Logothetis CJ, Kim J. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 117(3):469-77, 2016. e-Pub 2015. PMID: 25714186.
227. Papadimitrakopoulou VA, Frank SJ, Cohen EW, Hirsch FR, Myers JN, Heymach JV, Lin H, Tran HT, Chen CR, Jimeno A, Nedzi L, Vasselli JR, Lowe ES, Raben D. Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma. Head Neck 38(3):439-47, 2016. e-Pub 2015. PMID: 25352401.
228. Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2016. e-Pub 2016. PMID: 26830697.
229. Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M, MR-Linac Consortium Clinical Steering Committee. The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance and Technical Development. Front Oncol 6:215, 2016. e-Pub 2016. PMID: 27790408.
230. Holliday EB, Kocak-Uzel E, Feng L, Thaker NG, Blanchard P, Rosenthal DI, Gunn GB, Garden AS, Frank SJ*. Dosimetric advantages of intensity modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis. Med Dosim 41(3):189-94, 2016. e-Pub 2016. PMID: 27158021.
231. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: Preliminary results from a prospective pilot study. NMR Biomed 28(12):1645-54, 2015. e-Pub 2015. PMID: 26451969.
232. Grant SR, Walker GV, Koshy M, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast or gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 93(5):968-75, 2015. e-Pub 2015. PMID: 26452570.
233. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient-reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-8, 2015. e-Pub 2015. PMID: 26403258.
234. Thaker NG, Frank SJ, Feely TW. Comparative costs of advanced proton and photon radiation therapies: Lessons from time-driven activity-based costing in head and neck cancer. Journal of Comparative Effectiveness Research. e-Pub 2015.
235. Hartman J, Kontaxis C, Bol GH, Frank SJ, Lagendijk JJ, Van Vulpen M, Raaymakers BW. Dosimetric feasibility of intensity modulated proton therapy in a transverse magnetic field of 1.5 T. Phys Med Biol 60(15):5955-69, 2015. e-Pub 2015. PMID: 26182957.
236. Kudchadker RJ, Sandeep K, Lim T, Du W, Bruno TL, Frank SJ*. Evaluation of the MIM Symphony treatment. Journal of Applied Clinical Medical Physics 16(5), 2015. e-Pub 2015. PMID: 26699290.
237. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?. Pract Radiat Oncol 5(4):e299-308, 2015. e-Pub 2014. PMID: 25544553.
238. Pan HY, Jiang S, Sutton J, Liao Z, Chance WW, Frank SJ, Zhu XR, Li H, Fontanilla HP, Zhang X, Gomez DR. Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series. Pract Radiat Oncol 5(4):e345-53, 2015. e-Pub 2015. PMID: 25572666.
239. Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn GB, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong JH, Hung TM, Kocak Uzel E, Lewis GL, Frank SJ*. Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity Modulated Proton Therapy (IMPT) and Intensity Modulated Photon Therapy (IMRT). Int J Particle Therapy. Int J Particle Therapy, 2015. e-Pub 2015.
240. Zhu XR, Li Y, Mackin D, Li H, Poenisch F, Lee AK, Mahajan A, Frank SJ, Gillin MT, Sahoo N, Zhang X. Towards effective and efficient patient-specific quality assurance for spot-scanning proton therapy. Cancers (Basel) 7(2):631-47, 2015. e-Pub 2015. PMID: 25867000.
241. Li H, Zhang X, Park P, Liu W, Chang J, Liao Z, Frank SJ, Li Y, Poenisch F, Mohan R, Gillin M, Zhu R. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol 114(3):367-72, 2015. e-Pub 2015. PMID: 25708992.
242. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2015. e-Pub 2014. PMID: 25444304.
243. Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD. Quality Assurance Assessment of Diagnostic and Radiation Therapy-Simulation CT Image Registration for Head and Neck Radiation Therapy: Anatomic Region of Interest-based Comparison of Rigid and Deformable Algorithms. Radiology:132871. e-Pub 2014. PMID: 25380454.
244. Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ*. Establishing High Quality Prostate Brachytherapy using a Phantom Simulator Training Program. Int J Radiat Oncol Biol Phys 90(3):579-86, 2014. e-Pub 2014. PMID: 25151539.
245. Sniegowski MC, Warneke CL, Morrison WH, Nasser QJ, Frank SJ, Pfeiffer ML, El-Sawy T, Esmaeli B. Correlation of American Joint Committee on Cancer T Category for Eyelid Carcinoma With Outcomes in Patients With Periocular Merkel Cell Carcinoma. Ophthal Plast Reconstr Surg 30(6):480-485, 2014. e-Pub 2014. PMID: 24841735.
246. Haque W, Wages C, Zhu XR, Choi S, Pugh TJ, Frank SJ, Lee A, Mahmood U. Proton therapy for seminoma: Case report describing the technique, efficacy and advantages of proton-based therapy for seminoma. Pract Radiat Oncol. e-Pub 2014. PMID: 25413401.
247. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer. Otolaryngol Head Neck Surg 151(4):619-26, 2014. e-Pub 2014. PMID: 25104816.
248. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer 120(19):3082-8, 2014. e-Pub 2014. PMID: 24898672.
249. Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ*. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil. Brachytherapy 14(2):160-165. e-Pub 2014. PMID: 25255712.
250. Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H. Defining a Standard Set of Patient-Centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 67(3):460-470. e-Pub 2014. PMID: 25234359.
251. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G, Expert Panel on Radiation Oncology–Prostate. Response to Drs. Rogers, Hayes and Demanes. Brachytherapy 13(5):523-5, 2014. e-Pub 2014. PMID: 24880587.
252. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ*. Magnetic Resonance Image Guided Brachytherapy. Semin Radiat Oncol 24(3):181-91, 2014. PMID: 24931089.
253. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice. Int J Radiat Oncol Biol Phys 89(4):846-53, 2014. e-Pub 2014. PMID: 24867532.
254. Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ, American College of Radiology, Expert Panel on Radiation Oncology Prostate. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 prostate cancer. Am J Clin Oncol 37(3):278-88, 2014. PMID: 25180754.
255. Holliday EB, Frank SJ*. Proton Radiation Therapy for Head and Neck Cancer: A Review of the Clinical Experience to Date. Int J Radiat Oncol Biol Phys 89(2):292-302, 2014. e-Pub 2014. PMID: 24837890.
256. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ*. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol 59(10):2505-2516, 2014. e-Pub 2014. PMID: 24778352.
257. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs at risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 111(2):281-8, 2014. e-Pub 2014. PMID: 24746582.
258. Melhus CS, Mikell JK, Frank SJ, Mourtada F, Rivard MJ. Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy. Brachytherapy 13(3):304-10, 2014. e-Pub 2013. PMID: 24139289.
259. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: Results from a randomized trial. Int J Radiat Oncol Biol Phys 88(5):1074-84, 2014. PMID: 24661661.
260. Mahmood U, Pugh T, Frank SJ, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy 13(2):157-62, 2014. e-Pub 2013. PMID: 24050892.
261. Zhu XR, Poenisch F, Li H, Zhang X, Sahoo N, Wu RY, Li X, Lee AK, Chang EL, Choi S, Pugh T, Frank SJ, Gillin MT, Mahajan A, Grosshans DR. A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol 9:202, 2014. e-Pub 2014. PMID: 25212571.
262. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy 13(1):27-31, 2014. e-Pub 2013. PMID: 24368283.
263. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a Phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy 13(1):68-74, 2014. e-Pub 2013. PMID: 23669149.
264. Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 87(5):946-53, 2013. e-Pub 2013. PMID: 24139077.
265. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis 16(4):346-51, 2013. e-Pub 2013. PMID: 23939133.
266. El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary Management of Lacrimal Sac/Nasolacrimal Duct Carcinomas. Ophthal Plast Reconstr Surg 29(6):454-7, 2013. PMID: 24195987.
267. Bui M, Frank SJ, Nasser QJ, El-Sawy T, McLemore MS, Morrison WH, Esmaeli B. Multidisciplinary management of primary adenoid cystic carcinoma of the eyelid with perineural invasion. Ophthal Plast Reconstr Surg 29(6):e143-6, 2013. e-Pub 2013. PMID: 23446295.
268. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study. Head Neck 35(10):1490-8, 2013. e-Pub 2012. PMID: 23169304.
269. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, Van Vulpen M, Frank SJ*. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a Phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy 12(5):401-7, 2013. e-Pub 2013. PMID: 23380383.
270. Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 2013. e-Pub 2013. PMID: 23798338.
271. Gunn GB, Debnam JM, Fuller CD, Morrison WH, Frank SJ, Beadle BM, Sturgis EM, Glisson BS, Phan J, Rosenthal DI, Garden AS. The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer. Cancer 119(17):3162-9, 2013. e-Pub 2013. PMID: 23733178.
272. Quan EM, Liu W, Wu R, Li Y, Frank SJ, Zhang X, Zhu XR, Mohan R. Preliminary evaluation of multi-field and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Med Phys 40(8):081709, 2013. PMID: 23927306.
273. Gillenwater AM, Frank SJ, Fatani H, El-Naggar AK. Primary intestinal-like adenocarcinoma of major salivary glands: Two instances of previously undocumented phenotype. Head Neck 35(8):E234-6, 2013. e-Pub 2012. PMID: 23108630.
274. Register SP, Kudchadker RJ, Levy LB, Swanson DA, Pugh TJ, Bruno TL, Frank SJ*. An MRI-based dose-response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a Phase II prospective trial. Brachytherapy 12(3):210-6, 2013. e-Pub 2013. PMID: 23466360.
275. Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H. MR Imaging of Prostate Cancer in Radiation Oncology: What Radiologists Need to Know. Radiographics 33(3):741-61, 2013. PMID: 23674772.
276. Cheung JP, Park PC, Court LE, Zhu XR, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys 40(5):051714, 2013. PMID: 23635262.
277. Liu W, Frank SJ, Li X, Li Y, Park PC, Dong L, Zhu XR, Mohan R. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 40(5):051711, 2013. PMID: 23635259.
278. Yang J, Beadle BM, Garden AS, Gunn B, Rosenthal DI, Ang K, Frank SJ, Williamson R, Balter P, Court L, Dong L. Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy. Pract Radiat Oncol 4(1):31-37. e-Pub 2013.
279. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason Score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-9, 2013. e-Pub 2012. PMID: 22673704.
280. Frank SJ, Johansen MJ, Martirosyan KS, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T. A biodistribution and toxicity study of cobalt dichloride-n-acetyl cysteine in an implantable MRI marker for prostate cancer treatment. Int J Radiat Oncol Biol Phys 85(4):1024-1030, 2013. e-Pub 2012. PMID: 23092727.
281. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 85(4):941-947, 2013. e-Pub 2012. PMID: 22975604.
282. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?. Int J Radiat Oncol Biol Phys 85(3):693-699, 2013. e-Pub 2012. PMID: 22836052.
283. Kandula S, Zhu X, Garden AS, Gillin M, Rosenthal DI, Ang KK, Mohan R, Amin MV, Garcia JA, Wu R, Sahoo N, Frank SJ. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: A treatment planning comparison. Med Dosim 38(4):390-4, 2013. e-Pub 2013. PMID: 23916884.
284. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol 8(1):21, 2013. e-Pub 2013. PMID: 23360540.
285. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 2013. e-Pub 2012. PMID: 23102837.
286. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ*. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy 12(1):30-7, 2013. e-Pub 2012. PMID: 22727474.
287. Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Yeh SF, Frank SJ*. Knife or Needles? A Cohort Analysis of Outcomes after Radical Prostatectomy or Brachytherapy for Men with Low- or Intermediate-Risk Adenocarcinoma of the Prostate. Brachytherapy 11(6):429-34, 2012. e-Pub 2012. PMID: 22727472.
288. Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 23(9):2346-52, 2012. e-Pub 2012. PMID: 22357249.
289. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?. Eur J Cancer 48(11):1664-71, 2012. e-Pub 2012. PMID: 22336663.
290. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-4, 2012. e-Pub 2011. PMID: 21875820.
291. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ*. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of rectal complications following brachytherapy. Pract Radiat Oncol 3(E):7-13. e-Pub 2012. PMID: 22727474.
292. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI. Unilateral Radiotherapy for the Treatment of Tonsil Cancer. Int J Radiat Oncol Biol Phys 83(1):204-9, 2012. e-Pub 2011. PMID: 22019242.
293. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ*. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys 82(5):e765-71, 2012. e-Pub 2012. PMID: 22300559.
294. Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y. ACR Appropriateness Criteria(®) External-Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer. J Am Coll Radiol 9(4):233-8, 2012. PMID: 22469373.
295. Hinnen KA, Monninkhof EM, Battermann JJ, Van Roermund JG, Frank SJ, Van Vulpen M. Prostate Specific Antigen Bounce Is Related to Overall Survival in Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 82(2):883-8, 2012. e-Pub 2011. PMID: 21300477.
296. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank SJ, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low-, intermediate- and high-risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU International 109 Suppl 1:22-9, 2012. PMID: 22239226.
297. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Pugh TJ, Swanson DA. Outcomes after prostate brachytherapy are even better than predicted. Cancer 118(3):839-47, 2012. e-Pub 2011. PMID: 21751187.
298. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: A 20-year analysis. Cancer J 18(1):1-8, 2012. PMID: 22290249.
299. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ*. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim 37(4):387-90, 2012. e-Pub 2012. PMID: 22560295.
300. Moran BJ, Derose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Yamada Y, Merrick GS, Expert Panel on Radiation Oncology-Prostate. ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer. Am J Clin Oncol 34(6):636-647, 2011. PMID: 22101389.
301. Expert Panel on Radiation Oncology-Prostate, Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria Permanent Source Brachytherapy for Prostate Cancer. Brachytherapy 10(5):357-62, 2011. e-Pub 2011. PMID: 21497562.
302. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, Van Vulpen M, Frank SJ*. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy 10(5):401-8, 2011. e-Pub 2011. PMID: 21306959.
303. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ*. Impact Of Urinary Catheterization On Dosimetry After Prostate Implant Brachytherapy With Palladium-103 Or Iodine-125. Brachytherapy 10(4):269-74, 2011. e-Pub 2011. PMID: 21296031.
304. Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ*. Outcomes of malignant tumors of the lacrimal apparatus: The University of Texas MD Anderson Cancer Center experience. Cancer 117(12):2801-10, 2011. e-Pub 2011. PMID: 21656758.
305. Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A. Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?. Int J Radiat Oncol Biol Phys 79(5):1310-7, 2011. e-Pub 2010. PMID: 20493642.
306. Rossi CJ, Joe Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Hahn NM, Moran BJ, Rosenthal SA, Merrick G. ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer. Am J Clin Oncol 34(1):92-98, 2011. PMID: 21270599.
307. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ*. Long-term Tumor Control After Brachytherapy for Cancer at the Base of the Prostate. J Contemp Brachytherapy 3(4):183-187, 2011.
308. Sharp HJ, Swanson DA, Patel H, Gorbatiy V, Frenzel JC, Frank SJ*. Subacute penile numbness after brachytherapy for prostate cancer. Brachytherapy 10(1):64-7, 2011. e-Pub 2010. PMID: 20685173.
309. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim 36(2):200-5, 2011. e-Pub 2010. PMID: 20537886.
310. Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive Sentinel Node in Sebaceous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, 2011. e-Pub 2010. PMID: 20940661.
311. Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Frank SJ, Beadle BM. Characteristics and Clinical Outcomes of Patients with Multiple Potentially HPV-Related Malignancies. Int J Radiat Oncol Biol Phys 78(3, Suppl):S441-S442, 2010.
312. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-Modulated Radiotherapy for Cervical Node Squamous Cell Carcinoma Metastases from Unknown Head-and-Neck Primary Site: MD Anderson Cancer Center Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys 78(4):1005-10, 2010. e-Pub 2010. PMID: 20207504.
313. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 2010. e-Pub 2010. PMID: 20171802.
314. Roeloffzen EM, Hinnen KA, Battermann JJ, Monninkhof EM, Van Roermund JG, Van Gellekom MP, Frank SJ, Van Vulpen M. The Impact of Acute Urinary Retention After Iodine-125 Prostate Brachytherapy on Health-Related Quality of Life. Int J Radiat Oncol Biol Phys 77(5):1322-8, 2010. e-Pub 2009. PMID: 19939578.
315. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin JS, Holsinger FC, Stasney CR, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing Intensity-Modulated Radiotherapy Technique and Preliminary Experience for T1-2 Glottic Cancer. Int J Radiat Oncol Biol Phys 77(2):455-61, 2010. e-Pub 2009. PMID: 19679406.
316. Hinnen KA, Battermann JJ, Van Roermund JG, Moerland MA, Jürgenliemk-Schulz IM, Frank SJ, Van Vulpen M. Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I-125 Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 76(5):1433-8, 2010. e-Pub 2009. PMID: 19540075.
317. Frank SJ, Kudchadker RJ, Kuban DA, de Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles during a Course of Intensity-Modulated Radiation Therapy. Am J Clin Oncol 33(2):173-5, 2010. PMID: 20010077.
318. Roeloffzen EM, Lips IM, van Gellekom MP, van Roermund J, Frank SJ, Battermann JJ, van Vulpen M. Health-Related Quality of Life up to Six Years After (125)I Brachytherapy for early-stage Prostate Cancer. Int J Radiat Oncol Biol Phys 76(4):1054-60, 2010. e-Pub 2010. PMID: 20097486.
319. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ*. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Urology 74(3):601-5, 2009. e-Pub 2009. PMID: 19589580.
320. Peterson S, Polf J, Ciangaru G, Frank SJ, Bues M, Smith A. Variations in Proton Scanned Beam Dose Delivery Due to Uncertainties in Magnetic Beam Steering. Med Phys 38(8):3693-3702, 2009. PMID: 19746802.
321. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ*. Late Rectal Complications after prostate brachytherapy for localized prostate cancer: Incidence and Management. Cancer 115(9):1827-1839, 2009. PMID: 19248043.
322. Moeller B, Rana V, Cannon B, Williams M, Sturgis E, Ginsberg L, Macapinlac H, Lee J, Ang KK, Chao KSC, Chronowski G, Frank SJ, Morrison W, Rosenthal D, Weber R, Garden A, Lippman S, Schwartz D. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27(15):2509-2515, 2009. e-Pub 2009. PMID: 19332725.
323. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram predicted brachytherapy outcomes are not universally accurate: An analysis based on the MD Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol 181(4):1658-63; discussion 1663-4. e-Pub 2009. PMID: 19233434.
324. Hsu A, Frank SJ, Ballo MT, Garden AS, Morrison WH, Rosenthal DI, Hatef E, Esmaeli B. Post-Operative Adjuvant External-beam Radiation Therapy for Cancers of the Eyelid and Conjunctiva. Ophthal Plast Reconstr Surg 24(6):444-449, 2008. PMID: 19033839.
325. McGuire SE, Frank SJ*, Eifel PJ (*corresponding author). Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy 7(4):359-63, 2008. e-Pub 2008. PMID: 18778972.
326. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ*. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era?. Int J Radiat Oncol Biol Phys 72(2):623-7, 2008. e-Pub 2008.
327. Frank SJ, Dong L, Kudchadker RJ, de Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 2008. e-Pub 2008. PMID: 18207664.
328. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI Marker for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 2008. PMID: 18406882.
329. Petsuksiri J, Frank SJ*, Garden AS, Ang KK, Morrison WH, Chao KS, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B (*corresponding author). Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer 112(1):111-8, 2008. e-Pub 2007. PMID: 17963262.
330. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Gordon W, Raben A, Strasser J, Kaproswki C, Frank SJ, Chronowski G, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 68(5):1512-21, 2007. PMID: 17674982.
331. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177(6):2151-6, 2007. PMID: 17509305.
332. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-4, 2007. e-Pub 2007. PMID: 17292459.
333. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67:1059-65, 2007. PMID: 17241755.
334. Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M, Clarke DH, Stock RG, Lee RW, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC. Interstitial Implant Alone or in Combination with External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer: A Survey of Practice Patterns in the United States. Brachytherapy 6(1):2-8, 2007. PMID: 17284379.
335. Patel S, Jagsi R, Wilson J, Frank S, Thakkar VV, Hansen EK. Results of the 2004 Association of Residents in Radiation Oncology (ARRO) Survey. Int J Radiat Oncol Biol Phys 66(4):1199-203, 2006. PMID: 16979833.
336. Lee AK, Frank SJ. Update on radiation therapy in prostate cancer. Hematol Oncol Clin North Am 20(4):857-878, 2006. PMID: 16861119.
337. Frank SJ, Chao KS, Schwartz DL, Weber RS, Apisarnthanarax S, Macapinlac HA. Technology Insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol 2(10):526-533, 2005. PMID: 16205772.
338. Callaghan EB, Padgett AV, Frank SJ. Self-Referral: What Residents Need to Know?. J Am Coll Radiol 2(5):452454, 2005. PMID: 17411855.
339. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive treatment of invasive squamous cell carcinoma of the vagina with radiation therapy. Int J Radiat Oncol Biol Phys 62(1):138-147, 2005. PMID: 15850914.
340. Jagsi R, Buck DA, Singh AK, Engleman M, Thakkar V, Frank SJ, Flynn D. Results of the 2003 Association of Residents in Radiation Oncology (ARRO) surveys of residents and chief residents in the United States. Int J Radiat Oncol Biol Phys 61(3):642-648, 2005. PMID: 15708241.
341. Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in radiation treatments of breast cancer. Clin Breast Cancer 4(6):401-406, 2004. PMID: 15023240.
342. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank SJ, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols. Med Dosim 29(2):80-84, 2004. PMID: 15191752.
343. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-1318, 2003. PMID: 12873675.

Invited Articles

1. Holliday EB, Frank SJ*. Current applications of proton beam radiation for the treatment of head and neck tumors. Otorinolaringo 64:1-11, 2014. e-Pub 2014.
2. Gunn GB, Frank SJ*. Advances in radiation oncology for the management of oropharyngeal tumors. Otolaryngol Clin North Am 46(4):629-43, 2013. e-Pub 2013. PMID: 23910474.
3. Eberhardt SC, Carter S, Casalino DD, Merrick G, Frank SJ, Gottschalk AR, Leyendecker JR, Nguyen PL, Oto A, Porter C, Remer EM, Rosenthal SA. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging and surveillance. J Am Coll Radiol 10(2):83-92, 2013. PMID: 23374687.
4. Pugh TJ, Frank SJ*. Quality Of Life Issues In The Radiotherapeutic Management Of Localized Prostate Cancer. Radiation Medicine Rounds 2(1), 2011.

Other Articles

1. Kaplan RS, Blackstone RP, Haas DA, Thaker NG, Frank SJ* Measuring and Communicating Health Care Value with Charts. Harvard Business Review.
2. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G, American College of Radiology Appropriateness Criteria American College of Radiology Appropriateness Criteria(®) - Locally Advanced (High-risk) Prostate Cancer. Clin Oncol (R Coll Radiol) 24(1):43-51, 2012. PMID: 21875782.
3. Martirosyan KS, Stafford RJ, Elliott AM, Frank SJ* PMMA/SWCNTs Composites for Prostate Brachytherapy MRI Contrast Agent Markers. Technical Proceedings of the 2009 NSTI Nanotechnology Conference and Expo 2:44-47, 2009.
4. Frank SJ, Curley MD, Ryder SJ A biomedical review of the U.S. Navy submarine escape system. Rep US Nav Submar Med Cent, 1997.

Editorials

1. Frank SJ*. Bending the slope of the brachytherapy curve: Magnetic resonance imaging-assisted radiosurgery for the treatment of prostate cancer. Brachytherapy 16(4):657-658, 2017.
2. Frank SJ*. Intensity-Modulated Proton Therapy for Head and Neck Tumors: Gilding the Lily or Holy Grail?. Int J Radiat Oncol Biol Phys 95(1):37-9, 2016. PMID: 27084621.
3. Lai SY, Fuller CD, Bhattacharya PK, Frank SJ*. Metabolic Imaging as a Biomarker of Early Radiation Response in Tumors. Clin Cancer Res 21(22):4996-8, 2015. PMID: 26232369.
4. Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE. Where Have You Gone Brachytherapy?. J Clin Oncol 33(9):980-2, 2015. PMID: 25667278.
5. Frank SJ. Oncology scan-demonstrating technology and measuring outcomes in head and neck cancer. Int J Radiat Oncol Biol Phys 88(4):759-60, 2014. PMID: 24606844.
6. Frank SJ, Yang T, Chao KSC. Role of PET-CT Fusion in Head and Neck Cancer. Oncology 2(19):246-249, 2005.
7. Frank SJ, Buchholz TA. Diminished Survival in Patients with Inner Versus Outer Quadrant Breast Cancers. Women's Oncology Review 3:157-158, 2003.

Abstracts

1. Sanders J, Mok H, Hanania A, Venkatesan A, Tang C, Bruno T, Thames H, Kudchadker R, Frank SJ*. Assessing the variability of contours performed by DL algorithms in prostate MRI. Int J Radiat Oncol Biol Phys, 2021.
2. Sanders J, Mok H, Levitt C, Tang C, Kudchadker R, Venkatesan A, Bruno T, Starks C, Santiago E, Cunningham M, Wells M, Weaver C, Frank SJ*. Autosegmentation in the clinic: Initial experiences with LDR prostate cancer patients from two MRI-based practices. Int J Radiat Oncol Biol Phys, 2021.
3. Sanders J, Mok H, Hanania A, Venkatesan A, Tang C, Bruno T, Thames H, Kudchadker R, Frank SJ*. Interobserver variability of target and OAR delineation in MRI-based prostate brachytherapy across two anatomical pulse sequences. Int J Radiat Oncol Biol Phys, 2021.
4. Sanders J, Mok H, Tang C, Hanania A, Venkatesan A, Bruno T, Kudchadker R, Thames H, Frank SJ*. Benchmarking automatic segmentation algorithms against human interobserver variability of prostate and organs at risk delineation on prostate MRI. Int J Radiat Oncol Biol Phys, 2021.
5. Sanders J, Mok H, Hanania A, Venkatesan A, Tang C, Bruno T, Thames H, Kudchadker R, Frank SJ*. Computer vision exhibits entropy similar to prostate cancer physicians. Int J Radiat Oncol Biol Phys, 2021.
6. Barbon CE, Peterson CB, Dirba DD, Gunn GB, Frank SJ, Ferrarotto R, Johnson FM, Hessel AC, Goepfert RP, Gross ND, Hutcheson KA. Comparison of Prospective, Longitudinal Swallowing Function after Primary Intensity-Modulated Proton Therapy (IMPT) or Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 108(3):S160-S160, 2020.
7. Wang L, Cao J, Liu Z, Lin E, Lu X, Li Y, Chen M, Kerr M, Wang X, Jiang B, Poenisch F, Yang M, Gautam AS, WU RY, Wang X, Zhang X, Swain J, Sahoo N, Zhu XR, Frank SJ*. Modulation Effect of CHK-1/-2 Inhibitor on Preclinical Head and Neck Cancer In Vivo Tumor Response to Proton and X-ray Radiation Therapy. Int J Radiat Oncol Biol Phys 108(3):E564-E565, 2020.
8. Sanders J, Frank S, Venkatesan A, Bathala T, Tang C, Kudchadker R, Bruno T, Pagel M, Ma J. OC-1034: Parallel imaging compressed sensing for prostate MRI without an endorectal coil: A prospective study. Radiother Oncol 152:S1088-S1089, 2020.
9. Sanders J, Venkatesan A, Davis J, Kudchadker R, Tang C, Bruno T, Ma J, Frank SJ*. OC-1040: Computer-aided brachytherapy: Assisting the practice of prostate brachytherapy with machine learning. Radiother Oncol 152:S1093-S1093, 2020.
10. Ng SP, Cardenas C, Bahig H, Elgohari B, Moreno A, Shah S, Garden A, Phan J, Gunn GB, Frank S, Rosenthal D, Morrison W, Wang J, Fuller C. PO-1691: Apparent diffusion coefficient changes in weekly MRI during radiotherapy in head and neck cancer. Radiother Oncol 152:S931-S931, 2020.
11. Ng SP, Cardenas CE, Bahig H, Elgohari B, Wang J, Johnson JM, Moreno AC, Shah SJ, Garden AS, Phan J, Gunn GB, Frank SJ, Ding Y, Na L, Yuan Y, Urbauer D, Rosenthal DI, Morrison WH, MacManus MP, Fuller CD. Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study. Int J Radiat Oncol Biol Phys 108(3):E790-E791, 2020.
12. Lin SH, Lei X, Liao K, Shaaban S, Chen AB, Lee P, Koong AC, Frank SJ, Liao Z, Giordano S, Smith GL. Comparing Healthcare Utilization, Hospitalization, and Costs with Neoadjuvant Intensity-Modulated Radiation Therapy (IMRT) versus Proton Beam Therapy (PBT) for Esophageal Cancer. Int J Radiat Oncol Biol Phys 108(3):S45-S46, 2020.
13. Kim M, Abu-Gheida I, Bathala T, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kuban DA, Aparicio A, Chapin B, Tang C. Comparisons of Treatment Outcomes and Patterns of Lymph Node Involvement in T4 Prostate Cancer Patients. Int J Radiat Oncol Biol Phys 108(3):E912-E912, 2020.
14. Engeseth GM, He R, Mirkovic D, Yepes P, Stokkevag CH, Pettersen HE, Wahid KA, Adair A, Wu R, Zhang X, Mohamed AA, Fuller CD, Frank S, Mohan R, Gunn GB. PD-0178: NTCP model development and comparison for brain image changes after IMPT for head and neck cancer. Radiother Oncol 152:S87-S87, 2020.
15. Elhalawani H, Volpe S, Cardenas CE, Stieb S, Rock C, Lin T, Yang P, Wu H, Barua S, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, Mohamed AS, Court LE, Gunn GB, Rosenthal DI, Frank SJ*. Investigation of Longitudinal Dose-Weighted FDG-Positron Emission Tomography Metabolic Imaging Biomarkers (PET MIBs) of Radiation-Associated Dysphagia in OPC Cohort. Int J Radiat Oncol Biol Phys 108(3):E312-313, 2020.
16. Dalwadi SM, Thames HD, Tang C, Crook JM, Sanders J, Blanchard P, Ciezki JP, Keyes M, Merrick GS, Catton CN, Razlee H, Stock RG, Sullivan F, Millar JL, Frank SJ*. Is The Phoenix Criterion Of Biochemical Failure (BF) In Men Treated With Low-Dose Rate Prostate Brachytherapy Appropriate?. Int J Radiat Oncol Biol Phys 108(3):E908-909, 2020.
17. Chen M, Wang Z, Adair AH, Yepes P, Sun J, Jiang S, Xu C, Chen J, Gunn GB, Frank SJ, Nguyen QN, Chang JY, Liao Z, Sahoo N, Zhu XR, Zhang X. Have We Underestimated the Risk of Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer Patients Receiving Proton Therapy Using Constant RBE?. Int J Radiat Oncol Biol Phys 108(3):E119-E120, 2020.
18. Bronk JK, Augustyn A, Mohamed AS, Wang R, Frank SJ, Fuller CD, Garden AS, Moreno AC, Morrison WH, Phan J, Reddy J, Rosenthal DI, Zafereo M, Ferrarotto R, Cabanillas ME, Gunn GB. Patterns Of Loco-Regional Failure And Outcomes After Intensity Modulated Radiation Therapy For Unresectable Anaplastic Thyroid Cancer. Int J Radiat Oncol Biol Phys 108(3):E849-E850, 2020.
19. Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson C, Frank S, Followill D. PO-1754: A stereoscopic CT artifact reduction method image quality comparison to current vendor solutions. Radiother Oncol 152:S975-S976, 2020.
20. Branco D, Taylor P, Kry S, Zhang X, Rong J, Frank S, Followill D. PD-0184: Proton dosimetric comparison of CT metal artifact reduction techniques for head and neck patients. Radiother Oncol 152:S90-S91, 2020.
21. Sosa A, Wang C, Nguyen T, Reddy J, Moreno A, Garden A, Rosenthal D, Frank SJ, Fuller C, Shah S, Morrison W, Gunn B, Su S, Phan J. Gamma Knife Boost for Head and Neck Cancers with Skull Base Extension: A Case Series. Int J Radiat Oncol Biol Phys 108(2):E49-E49, 2020.
22. Pasalic D, Ludmir E, Thaker N, Gunn B, Hanna E, Su S, Ferrarotto R, Glisson B, Reddy J, Fuller C, Phan J, Rosenthal D, Morrison W, Garden A. Frank SJ*. Prospective Patient-Reported Outcomes, Physician-Assessed Toxicities, and Treatment Outcomes in Sinonasal Malignancies Following Proton Beam Therapy. Int J Radiat Oncol Biol Phys 108(2):E14-E15, 2020.
23. Gunn Gb, Ferraroto R, Johnson FM, Bell D, Cardoso R, Johnson JM, Rubin ML, Yuan Y, Frank SJ, Fuller CD, Rosenthal DI, Kupferman ME, Goepfert R, Hessel AC, Hutcheson KA, Gross ND. Prospective, longitudinal digital activity monitoring before and after treatment of low-risk oropharyngeal squamous cell carcinoma: A feasibility study. Journal of Clinical Oncology 38(15), 2020.
24. Hanania AN, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Phan J, Reddy JP, Moreno AC, Ausat N, Myers NJ, Ferrarotto R, Frank SJ*. Intensity Modulated Proton Therapy (IMPT) to the Parotid Gland: A Seven-Year Experience. Int J Radiat Oncol Biol Phys 106(5):1195-1196, 2020.
25. Ferrarotto R, Mitani Y, Karpinets T, Frank SJ, Song X, Fan Y, Liu B, Bell D, Kupferman ME, Futreal PA, Zhang J, Heymach J, El-Naggar AK. Integrative proteomic and transcriptomic analysis define adenoid cystic carcinoma subgroups with distinct therapeutic targets. Int J Radiat Oncol Biol Phys 106(5):1190-1190, 2020.
26. Stieb S, Perez-Martinez I, Rock S, Mohamed AS, Bajaj N, Deshpande TS, Garden AS, Reddy JP, Phan J, Morrison WH, Frank SJ, Rosenthal DI, Koay EJ, Fuller CD, Gunn GB. Late Oral Toxicity after Photon Radiotherapy for Oropharyngeal Cancer Patients with Tongue-Lateralizing and Tongue-Depressing Oral Stents. Int J Radiat Oncol Biol Phys 106(5):1202-1203, 2020.
27. Phan J, Bagley A, Adam G, Frank SJ, Gunn GB, Rosenthal DI, Reddy J, Fuller CD, Morrison WH, Shah SJ, Moreno AC, Ferrarotta R, Sturgis EM, Gross ND. Reirradiation with SBRT, IMRT and Proton Therapy for Recurrent Oropharynx Squamous Cell Carcinoma: Efficacy and Toxicity Outcomes. Int J Radiat Oncol Biol Phys 106(5):1144-1144, 2020.
28. Ausat N, Rosenthal DI, Gunn GB, Ye R, Garden AS, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Bahig H, Sturgis EM, Glisson BS, Frank SJ*. Outcomes following Proton Therapy for Squamous Cell Carcinoma of the Larynx. Int J Radiat Oncol Biol Phys 106(5):1213-1213, 2020.
29. Crook JM, Tang C, Thames H, Blanchard P, Sanders J, Ciezki JP, Keyes M, Merrick GS, Catton CN, Raziee H, Stock R, Sullivan F, Anscher M, Frank SJ*. Validation of biochemical definition of cure after low-dose rate prostate brachytherapy. Journal of Clinical Oncology 38(6), 2020.
30. Zhu XR, Gillin M, Li H, Li Y, Lii MF, Taylor MB, Zhang X, Poenisch F, Sahoo N, Frank SJ*. Towards an Efficient and Effective Patient Specific QA Program For IMPT. 51st Annual Meeting of Particle Therapy Co-Operative Group (PTCOG51). e-Pub 2015.
31. Thaker NG, Frank SJ, Feeley TW. Comparative costs of proton and x-ray therapies for advanced head and neck cancer: Lessons from Time-driven Activity-based Costing. Commentary. Journal of Comparative Effectiveness Research. e-Pub 2015.
32. Thaker, NG, Guzman AB, Feeley TW, Jones TM, Incalcaterra JR, Kolom C, Tatum LS, Walters RS, Cantor S, Rosenthal DI, Garden, AS, Gunn GB, Fuller, CS, Palmer MB, Frank SJ . Defining the Value of Proton Therapy in an Evolving Healthcare System Using. Oncology Payers, 2014.
33. Thaker NG, Kudchadker RJ, Frank SJ. A Phantom-Based Simulator Approach to Improving the Quality of Prostate Brachytherapy Training. American Radium Society’s 96th Annual Meeting, 2014.
34. Melhus CS, Mikell JK, Frank SJ, Mourtada F, Rivard MJ. Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy. Brachytherapy 13(3), 2013.
35. Liu W, Frank SJ, Li X, Li Y, Zhu XR, Mohan R. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys 40(2):021709, 2013. PMID: 23387732.
36. Frank SJ, Rosenthal DI, Ang K, Sturgis EM, Chambers MS, Gunn GB, Hutcheson KA, Zhu XR, Palmer MB, Garden A. Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients - A case-control study. Proceedings from ASTRO 2013, 2013.
37. Hutcheson KA, Lewin JS, Garden AS, Rosenthal DI, Weber RS, William Jr WN, Gunn GB, Morrison WH, Fuller CD, Frank SJ. Early experience with IMPT for the treatment of oropharyngeal tumors: Acute toxicities and swallowing-related outcomes, 2013.
38. Frank SJ, Cox JD, Gillin M, Rosenthal DI, Garden AS, Ang K, Mohan R, Palmer MB, Amin M, Zhu XR. Intensity modulated proton therapy for head-and-neck cancer: The first clinical experience. Int J Radiat Oncol Biol Phys 84(3):S475-76, 2012.
39. Pugh TJ, Choi S, Nguyen Q, De Gracia B, Munsell MF, Frank SJ, Kuban DA, Hoffman KE, McGuire SE, Lee AK. Quality of Life and Toxicity Between Passively Scattered and Spot-Scanning Proton Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 84(3):S392-393, 2012.
40. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Brandon Gunn G, Kupferman ME, Ang KK, Rosenthal DI. Unilateral Radiotherapy for the Treatment of Tonsil Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2011. PMID: 22019242.
41. Poenisch F, Sahoo N, Taylor MB, Grosshans DR, Frank SJ, Lii M, Wu R, Zhang X, Gillin M, Zhu XR. Verification of Multi-field Optimized Proton Pencil Beam Treatment Plans. Int J Radiat Oncol Biol Phys 81(2):S879, 2011.
42. Christensen EN, Pugh TJ, Munsell MF, Swanson DA, Kudchadker RJ, Bruno TL, Brown AP, Frank SJ. Sector Analysis of Prostate Brachytherapy Shows That Low Doses can Achieve an Undetectable PSA. Int J Radiat Oncol Biol Phys 81(2):S422, 2011.
43. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, Frank SJ. Improving Prostate Brachytherapy Quality Assurance with MRI-Based Sector Analysis in a Phase II Prospective Trial. Int J Radiat Oncol Biol Phys 81(2):S209, 2011.
44. Nguyen Q, Crawford C, Palmer M, Zhu R, Choi S, Pugh T, Frank SJ, Hoffman K, Kuban DA, Lee AK. Utilizing A Multifield Optimization Intensity Modulated Proton Technique (MFO-IMPT) To Deliver A Simultaneous Integrated Boost (SIB) To The Dominant Intraprostatic Lesion For Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 81(2):S876-S877, 2011.
45. Beadle BM, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Frank SJ, Hessel AC, Ang KK. Outcomes and Risk Factors in Patients Treated with Surgery and Postoperative Radiation Therapy Alone: A Subset Update of a Randomized Trial. Int J Radiat Oncol Biol Phys 81(2):S104-S105, 2011.
46. Rosenthal DI, Fuller CD, Holsinger F, Morrison W, Weber RS, Ang K, Frank SJ, A.S. Garden. Conditional Survival for Locally Advanced Larynx Cancer. Int J Radiat Oncol Biol Phys 81(2):S516, 2011.
47. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh T, McGuire SE, Kuban DA. Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?. Int J Radiat Oncol Biol Phys 81(2):S40-S41, 2011.
48. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Choi S, Nguyen Q, Hoffman K, McGuire SE, Swanson DA. Prediction of Extraprostatic Extension in Intermediate Risk Prostate Cancer: The Evolving Role of Endorectal MRI. Int J Radiat Oncol Biol Phys 81(2):S398, 2011.
49. Garden AS, Morrison WH, Stugis EM, Dong L, Glisson BS, Frank SJ, Kies MS, Weber RS, Ang KK, Rosenthal DI. IMRT for Oropharyngeal Carcinoma: Patient Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys 81(2):S15-S16, 2011.
50. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Pugh TJ, Swanson DA. Outcomes after prostate brachytherapy are even better than predicted. Cancer. e-Pub 2011. PMID: 21751187.
51. Melhus CS, Mourtada F, Mikell JK, Frank SJ, Rivard MJ. Dosimetric Influence of Brachytherapy Seed Spacers. Brachytherapy 10(1, Suppl):S94 - S95, 2011.
52. Pugh TJ, Frank SJ, Kudchadker R, Swanson DA, Davis JW. Prostate MRI in Men With Intermediate-Risk Prostate Cancer: Implications for Prostate Brachytherapy Monotherapy. Brachytherapy 10(1, Suppl):S30, 2011.
53. Frank SJ, Munsell MF, Pugh TJ, Kudchadker RJ, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Swanson DA. Long-Term Outcomes, Quality of Life and Patient-Reported Satisfaction Following Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Brachytherapy 10(1, Suppl):S16-S17, 2011.
54. Rosenthal DI, Gunn GB, Mendoza TR, Garden AS, Beadle BM, Morrison WH, Wang XS, Frank SJ, Weber RS, Ang KK, Cleeland CS. Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques. J Clin Oncol 29(15S):369s, 2011.
55. Gunn GB, Mendoza TR, Garden AS, Wang XS, Morrison WH, Frank SJ, Hanna EY, Lu C, Beadle BM, Ang KK,Cleeland CS, Rosenthal DI. Patient-reported fatigue in head and neck cancer survivors. J Clin Oncol 29(15S):365s, 2011.
56. Papadimitrakopoulou V, Heymach J, Frank SJ, Myers J, Lin H, Tran HT, Chen C, Hirsch FR, Langmuir PB, Vasselli JR, Lippman SM, Raben D. Updated clinical and biomarker results from a Phase I study of vandetanib with radiation therapy (RT) with or without cisplatin in locally advanced head and neck squamous cell carcinoma (HNSCC). J Clin Oncol 29(15S):362s, 2011.
57. Frank SJ, Johansen MJ, Martirosyan K, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T. A Toxicokinetic Evaluation Of Intraprostatically Administered Cobalt Dichloride - N - Acetyl Cysteine (CoCI2-NAC) Conjugate In A Rat Model Of Systemic Exposure. Int J Radiat Oncol Biol Phys 81(2):S433 - S434, 2011.
58. Gunn GB, Garcia SM, Beadle BM, Hanna EY, William WN, Garden AS, Morrison WH, Frank SJ, Ang KK, Rosenthal DI. Skin Culture and Treatment Results in Head and Neck Cancer Patients With Severe Radiation Dermatitis and Potential Suprainfection. Int J Radiat Oncol Biol Phys 78(3, Suppl):S175, 2010.
59. Albert JM, Zhang M, Bruno TL, Kudchadker RJ, Swanson DA, Frank SJ. MRI-Based Treatment Planning for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S372-S373, 2010.
60. Kuban DA, Nogueras-Gonzales GM, Hamblin L, Lee AK, Choi S, Frank SJ, Nguyen QN, Hoffman KE, McGuire SE, Munsell MF. Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation. Int J Radiat Oncol Biol Phys 78(3, Suppl):S58-S59, 2010.
61. Nguyen Q, Levy LB, Lee AK, Choi S, Frank SJ, Hoffman K, McGuire S, Kuban DA. Risk Factors Predicting Failure and Prostate Cancer Mortality in High-Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S125, 2010.
62. Kim MM, Hoffman KE, Levy LB, Master P, Frank SJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in Prostate Cancer Outcomes Over Time: A 20-Year Analysis. Int J Radiat Oncol Biol Phys 78(3, Suppl):S191-S192, 2010.
63. Morikawa LK, Kudchadker R, Kanke J, Oyervides M, Frank SJ, Lee AK, Hoffman K, Choi S, Nguyen Q, Kuban D. Endorectal Balloon in Post-Operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 78(3, Suppl):S395, 2010.
64. McGuire SE, Levy LB, Settle SH, Choi S, Nguyen Q, Hoffman K, Frank SJ, Lee AK, Kuban D. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High-Dose Radiotherapy Predicts Survival in Clinically Localized High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 78(3, Suppl):S124-S125, 2010.
65. Mendoza TR, Gunn GB, Wang XS, Frank SJ, Beadle BM, Shah SH, Lu C, Hanna EY, Cleeland CS, Rosenthal DI. Impact of Symptom Burden on Survival in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S470-S471, 2010.
66. Zhang M, Munsell MF, Swanson DA, Kudchadker RJ, Albert JM, Urbauer DL, Duban DA, Bruno TL, Frank SJ. Patients Can Expect Long-Term Satisfaction After Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S367, 2010.
67. Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Choi S, Nguyen QN, Frank SJ. Prostate Cancer-Specific Survival and Time to Recurrence Outcomes for Men Treated With Radical Prostatectomy, Intensity Modulated Radiation Therapy, or Brachytherapy at MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys 78(3, Suppl):S147-S148, 2010.
68. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Swanson DA. Prostate Cancer Outcomes Following Brachytherapy Are Superior To Those Predicted By the Prostogram. Int J Radiat Oncol Biol Phys 78(3, Suppl):S148, 2010.
69. Choi S, Johnson JL, de Crevoisier R, Lee AK, Dong L, Frank SJ, Nguyen Q, Kuban DA. Comparison of Alignment Using Transabdominal Ultrasound Versus Computed Tomography for Prostate Cancer Patients Treated with Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy. Oncology 24(4, S3):53, 2010.
70. Fisher CM, Troncoso P, Kuban DA, Munsell MF, Yeh S, Lee AK, Swanson DA, Frank SJ. Do African American and White Men Have Differences in Their Rate of Pathological Upgrading? An MD Anderson Cohort Study of Radical Prostatectomy, Brachytherapy and External Beam Patients Treated From 2000-2001. Oncology 24(4, S3):50, 2010.
71. Shirvani SM, Kudchadker RJ, Bruno TL, Swanson DA, Frank SJ. Letting the Catheter Out of the Bag: The Effect of Urinary Catheterization on Post-Implant Dosimetry After Prostate Brachytherapy with Palladium-103. Oncology 24(4, S3):49, 2010.
72. Ludwig MS, Lev L, Frank SJ, Hoffman K, Lee AK, McGuire SE, Nguyen QN, Choi S, Woodward W, Kuban DA. Influence of Prognostic Factors on Duration of Hormone Therapy and Outcomes. Oncology 24(4, S3):46, 2010.
73. Sharp HJ, Swanson DA, Zhang M, Phan J, Bruno TL, Kudchadker R, Kuban DA, Lee AK, Choi S, Nguyen Q, Frank SJ. Prostate Brachytherapy Preceded by Screening Colonoscopy Diagnoses Colorectal Cancers in Asymptomatic Patients. Oncology 24(4, S3):46, 2010.
74. Frank SJ, Register S, Levy LB, Kudchadker R, Bruno TL, Swanson DA. An MRI Dose Response Analysis for Urinary Morbidity Following Prostate Brachytherapy Monotherapy in a Phase II Prospective Trial. Brachytherapy 9(2, S1):S42, 2010.
75. Frank SJ. Cobalt Chloride Complex Contrast (C4) agent is safe for MRI-based Prostate Brachytherapy: A Toxicokinetic Evaluation of Intraprostatic Administration in a Rat Model. American Radium Society 92nd Annual Meeting, 2010.
76. Frank SJ, Tailor R, Martirosyan K, Stafford J, Swanson D, Sing D, Choi J, Elliot A, Mourtada F, Kudchadker R, Ibbott G. C4 MRI ECAMS have no effect on I see anisotropy and are visibile after radiation exposure. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 2009.
77. Whaley JT, Levy LB, Swanson DA, Kudchadker RJ, Bruno TL, Frank SJ. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 2009.
78. Parker PA, Latini DM, Ward JF, Pettaway C, Pisters LL, Matin S, Frank SJ, Brown V, Kuban D, Logothetis C, Kim J, Davis JW. Association between uncertainty, anxiety, and quality of life in men with prostate cancer on active surveillance. Society of Behavioral Medicine 37, 2009.
79. Morikawa LK, Levy LB, Choi S, Nguyen QN, Cheung MR, Frank SJ, Lee A, Kuban DA. Relationship Between PSA Failure and Death From Prostate Cancer After Radical External Beam Radiation Therapy. Proceedings from ASTRO 2009 Annual Meeting, 2009.
80. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB, Frank SJ. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas MD Anderson Cancer Center. Proceedings from the Radium Society, 2008.
81. Vassiliev ON, Kudchadker RJ, Swanson DA, Kuban DA, Bruno TL, Frank SJ. Systematic Evaluation of Periurethral Stranded Seed Migration and its Dosimetric Consequences in Prostate Brachytherapy. Proceedings from ASTRO 2008, 2008.
82. Frank SJ, Fisher C, Levy LB, Kudchadker R, Kuban DA, Lee AK, Cheung RM, Choi S, Bruno TL, Swanson DA. Pre-implant Urinary Symptoms Predict for Worse Urinary Outcomes. Proceedings from ASTRO 2008, 2008.
83. Frank SJ, Stafford RJ, Bankson JA, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI-based Approach to Prostate Brachytherapy. Proceedings from the World Congress of Brachytherapy, 2008.
84. Frank SJ, Swanson DA, Kuban DA, Lee AK, Levy LB. Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the MD Anderson Cancer Center experience with I-125 brachytherapy. Proceeding from the World Congress of Brachytherapy, 2008.
85. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Bruno T, Swanson DA. Prostate Brachytherapy – The MD Anderson Cancer Center Experience. Proceedings from the American Urologic Association (AUA), 2008.
86. Anderson JF, Swanson DA, Kuban DA, Lee AK, Cheung RM, Choi S, Kudchadker R, Bruno T, Levy LB, Frank SJ. Long-term urinary complications following permanent prostate brachytherapy at the University of Texas MD Anderson Cancer Center. Proceedings from the Radium Society, 2008.
87. Martirosyan K, Stafford RJ, Bankson J, Frank S. Encapsulated Contrast Agent Marker (ECAM) for MRI Prostate Brachytherapy. Proceedings from The Minerals, Metals and Materials Society 2008 Annual Meeting, 2008.
88. Frank SJ, Petsuksiri J, Ang KK, Morrison WH, Chao KSC, Rosenthal DI, Schwartz DL, Chronowski G, Weber RS, Garden AS. Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma Metastatic to Cervical Lymph Nodes from an Unknown Primary Site; Outcomes and Patterns of Failure. Proceedings of ASTRO 49th Annual Meeting, 2007.
89. Cheung R, Tucker S, de Crevoisier R, Lee A, Frank SJ, Kudchadker R, Thames , Mohan R, Kuban D. Identification of the bladder dose and volume constraints to control late urinary toxicity after external beam radiotherapy for prostate cancer. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
90. Frank SJ, Pisters LL, David J, Lee AK, Cheung R, Swanson D, Bassett RL, Pettaway CA, Kuban DA. Quality of Life after Monotherapy Treatment for Localized Prostate Cancer: Implant (I-125), Radical Prostatectomy, and High Dose External Beam Radiation. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
91. Kanke JE, Amin MA, Wong P, Ang KK, Garden AS, Morrison WH, Chao KSC, Rosenthal D, Allen P, Frank SJ. Optimizing Head and Neck Radiation Treatment Planning Using an IMRT Monoisocentric Technique with a Static Low Anterior Neck Field. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
92. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KC, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B. Radiation Therapy for Squamous Cell Carcinoma of the Eyelid. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
93. Frank SJ. The implementation of heterogeneity corrections for lung cancer. Texas Radiological Society (TRS) 90th Annual Scientific Meeting, The Woodlands, TX, 2003.
94. Frank SJ. 45th Annual Scientific Meeting - ASTRO, Salt Lake City, UT, 2003.
95. Frank SJ. Treatment planning with heterogeneity corrections for Stage I/II lung cancer. Fletcher Society Annual Scientific Meeting, Las Vegas, NV, 2002.
96. Frank SJ. Heterogeneity vs. Homogeneity Corrections for Early Stage NSCLC. RSNA - Radiological Society of North America, Chicago, IL, 89th Annual Scientific Meeting, 2002.
97. Frank SJ. Definitive treatment of vaginal cancer with radiation therapy: The MD Anderson Cancer Center (MDACC) Experience. 1970-2000, 2000.

Book Chapters

1. Phan Jack, Frank SJ, Brown Paul D. Clinical Applications of Radiotherapy for Skull Base Tumors. In: Comprehensive Management of Skull Base Tumors. Second. Thieme Medical Publishers, Inc: New York, NY, 164-190, 2021.
2. Phan Jack, Frank SJ, Brown Paul D. Radiotherapy for Skull Base Tumors: Principles and Techniques. In: Comprehensive Management of Skull Base Tumors. Second. Thieme Medical Publishers, Inc: New York, NY, 141-163, 2021.
3. Frank SJ, Garden AS, Ang K. Principals and Techniques of Radiotherapy and Chemotherapy for Nasal Cavity and Paranasal Sinus Tumors. In: Tumors of Nose, Sinus and Nasopharynx. Thieme, Stuttgart: Germany, 2015.
4. Frank SJ, Gunn GB. Radiotherapy- The “Particle-rs” of energy, dose and delivery method. In: Otolaryngologic Clinics of North America: Oral Cavity and Oropharyngeal Cancer. Elsevier: Philadelphia, PA, 2013.
5. Frank SJ, Ahamad A, Ang KK. Cancer of the Nasal Cavity and Paranasal Sinuses. In: Clinical Radiation Oncology, 761-777, 2012.
6. Frank SJ, Selek U. Proton Beam Radiation Therapy for Head and Neck Malignancies. In: Curr Oncol Rep. 3, 202-7, 2010.

Books (edited and written)

1. Frank SJ, Xiaorong Ronald Zhu. Proton Therapy (Indications, Technique and Outcomes). Elsevier: Philadelphia, PA, 2020.